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ABSTRACT 
 
MASS SPECTROMETRY APPLIED TO PROBLEMS IN LIPID BIOCHEMISTRY: 
MICROCHIP BASED APPROACH FOR LIPIDOMICS PROFILING AND ANALYSIS 
OF LIPID METABOLITES BY LC-MS/MS 
 
 
By 
Tao Sun 
May 2012 
 
Dissertation supervised by Jana Patton-Vogt, Ph.D. 
 Lipidomics and metabolomics are powerful tools for the examination of cellular 
metabolism and physiology.  Methods for lipid analysis need to be developed that begin 
with small samples and do not overly dilute or disperse the sample in the separation 
process.  Microchips provide a platform for interfacing lysis of small cell populations 
with on-chip solid phase extraction for isolating lipid samples to generate high quality 
mass spectra from very small samples.  Chapter 1 of this dissertation presents a novel 
method for small scale lipidomics of bacterial cells by microchip based extraction 
coupled with untargeted profiling of glycerophospholipids using nanoelectrospray 
ionization mass spectrometry.  Chapter 2 and 3 focus on the development of LC-MS/MS 
methods to study biological pathways.  In Chapter 2, I describe a method for analysis of 
the phospholipids metabolite, GroPIns, in the medium of the pathogenic yeast Candida 
 v 
albicans.  This method was applied to aid in the characterization of the GroPIns transport 
protein, Git1, in C. albicans.  Chapter 3 extends the studies of part two and describes an 
efficient method based on HILIC-MS/MS for the separation and quantification of five 
lipid-related extracellular metabolites in yeast Saccharomyces cerevisiae.  This newly 
developed methodology was successfully applied to determine the extracellualr levels of 
glycerophosphoinositol, glycerophosphocholine, glycerol 3-phosphate, inositol and 
choline in wild type and mutant strains. 
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Chapter 1 
 
 
Novel Analytical Technique to Study 
Glycerophospholipids on a Microchip1 
 
 
 
 
 
 
 
 
1
The work described in this Chapter is reprinted with permission from: 
Sun, T.; Pawlowski, S.; Johnson, M. E. Highly efficient microscale purification of 
glycerophospholipids by microfluidic cell lysis and lipid extraction for lipidomics 
profiling, Analytical Chemistry, 2011, 83 (17), 6628-6634. Copyright (2011) American 
Chemical Society. 
 
 2 
1.1 Abstract 
 
In this chapter, a microfluidic chip-mass spectrometry based method for non-
targeted profiling of lipids from cell extracts is described.  The technique can in principle 
be used for lipid analysis in micro scale when working with small populations of cells (1 
to about 1000).  This is very often the case in biological applications in sample cleanup 
and separation for lipid identification.  The developed system packed with fresh silica 
beads allows for on-chip cell lysis and lipid extraction without any loss during the 
process, which is capable of being reused for the first four runs.  The acceptable 
extraction efficiency is obtained by integrating silica beads as the packing material with 
methanol as the eluent.  This work demonstrates the potential of incorporating microchip-
based lipid extraction into cellular lipidomics research.  The application of the 
methodology was extended to the discovery profiling of lipid from Sulfurospirillum 
barnesii strain SES-3 cells, which revealed the presence of 173 identified phospholipid 
species based on the high-resolution tandem mass spectrometry data.  The work has been 
published in the Analytical Chemistry journal (Sun et al., 2011).  The novelty of the 
microfluidic approach can be generally applied to any systems of interest and is the 
platform employed in microscale lipid studies in future research of our lab, it is thus 
imperative to describe its development in detail. 
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1.2 Introduction 
 
Lipids are a diverse group of biomolecules that are known to exist as thousands of 
distinct covalent entities, each with its unique structural and physical characteristics.  
They are essential cellular constituents that have multiple distinct roles in cellular 
functions.  It is commonly accepted that lipids are bioorganic hydrocarbon based 
molecules that are soluble in nonpolar solvents but are almost insoluble in water due to 
their makeup consisting mostly of carbon.  Lipids have various biochemical duties 
including energy storage (fats and sterols such as cholesterol), cell makeup such as lipid 
bilayers and micelles (phospholipids), and some are essential hormones (steroids and 
eicosanoids).  They play an important role as constituents of cellular membranes for 
separating cells from the external environment, compartmentalizing cells, and proving a 
special milieu for various biochemical processes.  The contribution of lipids to the 
composition of membrane in different organisms and cells varies depending upon the 
type and function of the structures [1-3].   
Phospholipids are present in all organisms, from archaebacteria, to plants, to 
humans [4].  These hydrophobic molecules are the building blocks for cellular 
membranes (lipid bilayer), yet perform a diverse number of other functions, from 
compartmentalization of cytoplasm to the housing of proteins involved in cell signaling, 
intercellular adhesion, and cytoskeletal support [5], as well as serving as a precursor pool 
for biologically active lipid mediators [6].  The two common structural classes of 
phospholipids found in eukaryotic cells are sphingomyelins and glycerophospholipids. 
Abundant glycophospholipids also are constituents of prokaryotic cells [7].  The general 
 4 
structure of glycerophospholipid (Figure 1-1) is that of a three-carbon sugar molecule 
with a fatty acyl or alkyl group at the sn-1, fatty-acyl groups at the sn-2 positions, and a 
characteristic phosphate ester group at the sn-3 position of glycerol.  The major distinct 
classes of glycerophospholipids are subdivided based on the nature of the polar “head 
group” at the sn-3 position of the glycerol backbone in eukaryotes and eubacteria or the 
sn-1 position in the case of archaebacteria [8].   
 
 
Figure 1-1 Structural relationships of glycerophospholipid classes.  Different classes have either 
ester (acyl), alkyl ether (alkyl) or vinyl ether (alk-10-enyl) substituents at sn-1, fatty-acyl 
substituents at sn-2, and a polar head group at the sn-3 position of glycerol. The abbreviations 
used throughout this review are indicated for each polar head group. 
 
Approximately 60% of the lipid mass of eukaryotic cell membrane are composed 
of phospholipids [9].  Minute changes in phospholipids can lead to major consequences 
on cell membrane function and viability.  Fatty acids that are esterified at the sn-1 and sn-
2 positions of the glycerol backbone can very in length from 14 to 22 carbons and can 
 5 
have from 0 to 6 double bonds [10].  The nomenclature of phospholipid is due to the 
polar head group: phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylinositol (PI), phosphatidylglycerol (PG), phosphatidylserine (PS) and 
phosphotidic acid (PA) as shown in Table 1-1.  The cell membrane has an asymmetrical 
distribution of phospholipids.  PE and PS are the major phospholipids found in the inner 
cytosolic membrane while the outer leaflet is primarily composed of PC [11].  Most cell 
membranes are composed of phosphatidyl linkages [9].  The sn-2 bond for the fatty acid 
is always an ester bond and unsaturated fatty acids are more possible.  The format x:y 
represents the number of carbons is x and the number of double bonds is y for the 
common notation of a molecular species.  Over 1000 individual molecular species of 
phospholipids can be devised in theory. 
 
Name Head group Structure 
Phosphatidylcholine Choline 
 
Phosphatidylinositol Inositol 
 
Phosphatidylglycerol Glycerol 
 
 6 
phosphatidylserine Serine 
 
Phosphatidylethanolamine Ethanolamine 
 
Table 1-1 Various polar head groups link to the phosphate group at the sn-3 poition. 
 
The quantitative study of lipids, or “lipidomics”, is a burgeoning field in 
bioanalytical chemistry [12-14].  Low detection limits are important to lipid studies 
because some lipids occur in trace (picomolar (10
-12
) to nanomolar (10
-9
)) and even 
ultratrace (femtomolar (10
-15
) and below) concentrations in samples [15-17].  Two 
branches of chemical analysis play an important role in “omics”: separation science and 
mass spectrometry.  In lipidomics, distinct subclasses of lipids, obtained by liquid 
extraction from a cell or tissue mass, are isolated by solid phase extraction, liquid 
chromatography, or thin-layer chromatography and then analyzed by a further dimension 
(or two) of liquid chromatography and two or more dimensions of mass spectrometry [9, 
18].  One difficulty in profiling the chemical population of a small sample is that the 
lipidome exists over a wide range of concentrations.  The most critical issue in analyzing 
such samples is that the less abundant species can easily get lost if the sample is wasted 
during inefficient sample processing steps.  In addition, a relatively large amount of 
sample is required in some commonly used techniques such as thin layer chromatography 
(TLC) [19, 20].  One way to overcome these issues is to reduce sample transfer steps and 
 7 
dead volume by applying a microchip platform for all or part of the sample preparation 
scheme. 
Micro total analysis system (μTAS) also called “lab-on-a-chip” is a novel 
technique of which the applications are addressing fundamental biological questions, 
creating new biomedical reagents, and developing innovative cell and biochemical assays  
that shrink an entire experimental device to the scale of a microscope slide [21, 22].   The 
system is able to offer improved performance, smaller amounts of sample consumption, 
lower cost, and higher throughput.  Additionally, it is essential for understanding 
physiologic and pathologic processes at the cellular level by investigating the 
intracellular contents of single cells.  Chemical analysis and chemical synthesis are the 
two main fields of μTAS, which are of significant interest to biological, medical, and 
pharmaceutical societies.  Many of these concepts were brought to fruition by the 
application of basic photolithography to creation of channels in glass microchips [23-27].     
During the past 2 decades, the field of microfluidics has grown to include not only chips 
that separate compounds by capillary electrophoresis (CE) [28] but also chips that create 
gradients, chips that integrate cell lysis with DNA capture, and even chips that allow for 
nanoscale reactions.  Highly assembled microchips have been developed to capture 
multiple single cells, lyse them, perform chemical reactions and detect chemical species 
in individual cells.  Cell lysis is generally performed by either chemical or physical 
methods to rupture the cell phospholipd membrane with the goal of extracting 
intracellular contents.  Different cell lysis methods have been developed on microfluidic 
platforms including chemical lysis, mechanical lysis, electrical lysis, thermal lysis, and 
other lysis methods.   
 8 
When on a chip, the use of reduced volumes of solvent and electrophoretic 
separation can eliminate the need for the centrifugation and resuspension.  This 
multidisciplinary field is comprised of physicists, chemists, engineers, and biologists all 
working to get the most out of these devices.  The ability of microfluidic devices to 
efficiently handle complex samples and subsequently perform the required analytical 
operations on the same chip will be essential to the final successful applications of 
microfluidic systems.  The integration of sample pretreatment within microfluidic devices 
has recently become an important area of emphasis in the field of μTAS.  However, there 
are very few reports in the area of microfluidic chips associated with lipid extraction for 
lipidomics analysis. 
The standard approach to lipid class isolation is based on either thin-layer 
chromatography (TLC) or solid-phase extraction (SPE), both of which are applied after a 
modified Bligh-Dyer extraction [29].  The biggest problem with TLC or SPE is that 
sample sizes are generally large (grams of tissue, >10
7
 cells).  In this chapter, a novel 
method for a microchip-based solid phase extraction for purification and enrichment of 
microscale glycerophospholipids is described.  Specifically, intact bacterial cells loaded 
onto a chip were immediately lysed to release their lipid content.  The released lipids 
were captured on a stationary phase and eluted with a suitable elution solvent.  The 
nonpolar tails of the membrane lipids were captured by the nonpolar C18 beads of the 
column, while the polar head groups of the lipids were captured by the polar silica beads. 
On-chip lipid extraction efficiency and reproducibility were evaluated by comparison to 
the modified Bligh-Dyer method [29].  The purified lipids were reconstituted and injected 
directly into a quadrupole-time-of-flight mass spectrometer (Q-TOF MS) for analyzing 
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lipids content in the membrane.  The characterization of phospholipids from lipid extracts 
by electrospray ionization (ESI) MS is based on the ability of each lipid class to acquire 
positive or negative charges when in solution under the ionization source high energy.  
Lipids that do not possess inherently ionizable moieties can also be ionized under the 
conditions of ESI.  As long as there is sufficient dipole potential for interaction with 
counter ions, these species can be analyzed. As a result under suitable conditions of 
sample preparation, all molecular species that exist among cellular lipid classes can be 
detected in a single run of an on-chip lipid extraction.  A single molecular ion with a 
mass-to-charge ratio (m/z) characteristic for the monoisotopic molecular weight is 
present for each molecular species.  The MS data were analyzed using both the METLIN 
Personal Metabolite database [30] and the LIPID MAPS (www.lipidmaps.org) database 
by integrating with MassHunter Qualitative Analysis software for lipidomics discovery 
profiling.  Several specific lipid databases and software packages have been developed 
(Table 1-2) over last ten years.  The approach of the LIPID MAPS has attempted to 
establish a standard platform for lipid nomenclature [14, 31].  METLIN Personal 
Metabolite database is designed specifically for metabolomics, which may also be 
employed for lipid identification and quantification.  With this method, we were able to 
identify over 170 phospholipid species from bacterial cell extracts. 
 
Name Comments Web site 
LIPID MAPS Open-access, Web search engine http://www.lipidmaps.org 
Lipid Bank Open-access, Web search engine http://lipidbank.jp 
METLIN Open-access, Web search engine http://metlin.scripps.edu 
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for metabolomics studies 
AMDMS-SL A freeware package designed for 
shotgun lipidomics  
http://www.shotgunlipidomics.com 
MZmine 2 A freeware package designed for 
metabolomics studies  
http://mamine.sourceforge.net 
LipidView Commercial software that 
performs complete data analysis 
http://www.mdssciex.com 
LIMSA A freeware package that can be 
downloaded from the Web 
http://www.helsinki.fi 
LipidX A subset of the systems biology 
freeware Systems X 
http://www.systemsm.ch 
LipidQA A freeware package that can be 
downloaded from the Web 
http://msr.dom.wustl.edu 
Table 1-2 Databases and software packages for lipid analysis. 
 
 
1.3 Experimental 
1.3.1 Reagents 
 
34:2 phosphatidylcholine (PC) and 34:1 phosphatidylinositol (PI) were purchased 
from Sigma-Aldrich (St. Louis, MO).  All solvents were HPLC grade from Fisher 
Scientific (Pittsburgh, PA) and were filtered through a 0.22 μm nylon membrane filter 
(Whatman).  Tri(hydroxymethyl) aminomethane (Tris) was from Fisher Scientific.  
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Omnipur egg white lysozyme was purchased from EMD Chemicals (Gibbstown, NJ).  A 
buffer solution for system washing was adjusted to 7.5 with 20 mM Tris 
 
 
1.3.2 Microchip Fabrication 
 
Microchips were fabricated roughly according to standard photolithographic 
technique [32].  Schott Borofloat glass plates (1.5mm thick, Telic Company, Santa 
Monica, CA) precoated with chrome and AZ 1518 negative photoresist (5300 Å thick) 
were used to fabricate microchips by standard photolithographic techniques [33].  The 
primary design for the microchips used in this study is a T-shape channel (Figure 1-2A).  
The image for the desired chip features were designed in Adobe Illustrator (CS2, Adobe, 
Inc.) and were printed on a high-resolution inkjet printer (Canon Pixma Pro900, 4800 × 
2400 dpi).  The chip features were clear on the photomask.  Clear glass covered by 
photomask was placed in a laminar flow hood, Arilean 600 PCR Workstation (Raleigh, 
NC) with a red light to prevent damaging the mask, and they were exposed under UV 
radiation , Spectroline SB-100PC of 60 MHz, 1.05 Amp, and long wavelength of 365nm 
(Westbury, NY), for transferring the pattern to the photoresist for 30 second.   
The exposed photomask blank was then placed in 15 mL of AZ 300 MIF 
developer (AZ electronics materials USA Corp., Somerville, NJ).  The solution was 
swirled over the top of the photomask blank for 30 seconds to solubilize the exposed 
region of the photoresist.  The developed blank was then rinsed with deionized water for 
40 seconds to remove the developer, after which it was placed in 25 mL of CR-9 
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Chromium Photomask Etchant (Cyantek Corp, Freemont, CA) and was swirled over the 
top of the photomask blank for 1-2 min until the chrome was removed.  The mask was 
then rinsed again for 40 seconds with deionized water to remove any remaining chrome 
in the channels.  Before the photomask blank was etched, the initial width of the channel 
was measured using a microscope with an optical scale, and determined to be 100 µm.  In 
order to produce a channel with a width of 300 μm and a depth of 200 μm, both top and 
bottom masks had line features that were 100 μm wide.  A channel with a total depth of 
200 μm was made by etching both the top and bottom of glass pieces 100 μm deep, and 
each channel was etched laterally by 100 μm, giving a channel that was 300 μm wide at 
its axis (Figure 1-2B).  The glass was etched using a 14:20:66 (v/v/v) HNO3/HF/H2O 
solution with the total etching time of 28 min.  The etching of the weirs in Figure 1-2C 
was observed under a light microscope and a zoom stereomicroscope (Leica Wild, 
Wetzlar, Germany), and the plate was rinsed with deionized water.  The remaining 
chrome and photoresist were removed and the glasses were washed thoroughly.   
Using an Accu Press drill (DynaArt Design, Lancaster, CA), and a diamond 
tipped drill bit (0.75mm), fluidic access holes were drilled in the wells at the end of each 
channel for capillary connections.  Water was poured onto the access holes while drilling 
to keep the glass from cracking.  More importantly, the drill bits would vaporize from 
heat if not cooled with water.  The chip glass was vigorously washed with deionized 
water.  Three pieces of the microchip were cut from the photomask blank using a 
glasscutter, and then rinsed with deionized water using a water spigot.  The drilled chips 
were placed in 15 mL of RS-120 Resist Stripper (Cyantek Corp., Fremont, CA) at 50 
o
C 
for 5 minutes to remove the remaining photoresist.  The solution was swirled until all of 
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the remaining resist had dissolved and then rinsed with deionized water for 2 minutes.  
The glass chips were then placed into CR-9 chrome etchant and swirled until the 
remaining chrome was dissolved.  After that, they were rinsed with deionized water and 
then placed in 15 mL of nanostrip (Cyantek Corp., Fremont, CA) to remove any 
remaining organic solvents on the chips.  The chips were then swirled in nanostrip for 3 
minutes and then rinsed again for 40 seconds in deionized water.  The water spigot was 
used to trace the channels to remove any excess debris.  The plates were subsequently 
placed in RCA solution, made up of 75.0 mL deionized water, 15.0 mL NH4OH mixed 
on a hot plate at 60°C.  15.0 mL of H2O2 was added to the RCA solution, after which the 
chips were put into this solution, and swirled for 30 minutes.  The chips were removed 
from the solution and each piece was rinsed and cleaned thoroughly for 5 minutes with 
deionized water using the water spigot to ensure proper bonding. 
The top and bottom chip were subsequently brought into contact while still wet 
and were held together by capillary action.  Finally, the assembly was placed in a furnace 
(Lindberg/Blue Moldatherm, Thermo Fisher Scientific Inc., Asheville, NC).  The furnace 
temperature was raised at a rate of 10 °C/min to 80 °C and was held for 30 min, after 
which it was ramped at the same rate to 610 °C and held for 8 h.  The temperature was 
then decreased to room temperature at a rate of 10 °C /min.  The chips were examined 
with the stereoscope to ensure that they were properly aligned and no shift occurred 
during the bonding process [34, 35].  The weir structures were fabricated by leaving a 
gap in the channels in the photomask that was etched only part way through.  The 
isotropic etching process created a very small open portion at the top with a sloping 
bottom in the channel.  When bonded to a top channel, the net result was a channel with a 
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double trapezoidal structure, 120 μm wide at top and bottom, 300 μm wide in the middle, 
with an elliptical weir that was about 10-15 μm wide at the widest (top to bottom) (Figure 
1-2). 
The microchip was firstly conditioned by sequentially pumping about 100 μL 
each of 1 M sodium hydroxide, deionized water, and methanol before packing.  The 
packing material used as the stationary phase was either spherical silica gel (100 Å, 20 
μm, Sorbent Technologies, Inc., Norcross, GA) or C18 silica gel (100 Å, Luna 15 μm, 
Phenomenex, Torrance, CA).  A slurry of packing material made with methanol was 
introduced to the reservoir on the side arm of the chip by applying a mild vacuum 
through the other two reservoirs using pipet tips attached to a vacuum pump (Figure 1-
2D).  The packing was done under a zoom stereomicroscope.  Once the chips were 
packed, the lower bead-hole of the T-shape was sealed with epoxy and left to dry 
overnight before use (Figure 1-2E).  Adhesives were placed around the other two wells, 
to which the nanoports were attached.  The nanoport of one well was connected with 
PEEK tubing of the injection pump, by which water was passed through the channel to 
test the flow of each chip. 
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Figure 1-2 Design of the microfluidic device. (A) The schematics of the microchip for cell lysis 
and lipid extraction. (B) Cross-sectional diagram of the SPE channel. (C, D) Images of the weir 
structure and the packed column. (E) Silica beads are packed in the microchannel through the 
bead-hole on the side-arm of the chip using a mild vacuum until the channel is fully packed. 
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1.3.3 Online Extraction System 
 
The home-built microfluidic chip apparatus for solid phase extraction consisted of 
a Harvard Apparatus model 11 syringe pump (Harvard Apparatus, Holliston, MA) and a 
250 μL Hamilton gastight syringe (Hamilton, Las Vegas, NV).  Reagents were injected 
using an HPLC type injection valve (Rheodyne 7725, Rohnert Park, MA) with a 40 μL 
injection loop.  The injection port was connected to the chip with polyether ether ketone 
(PEEK) tubing (1/16 in. o.d. × 0.010 in. i.d., Upchurch, Oak Harbor, WA) and custom 
pressure holders or Upchurch Nanoports (Figure 1-3).  To flush out any unreacted species 
and prepare the solid phase for extraction, freshly filled microchips were conditioned 
with 20 mM Tris buffer (pH 7.5) for 30 min at 10 μL/min.  The solid phase was 
reconditioned under the same conditions for 10 min before each extraction step.  The 
primary extraction protocol consisted of three pressure driven wash steps, each performed 
at a flow rate of 10 μL/min.  First, the injection valve was switched to “load” and 20 μL 
of the lysing agent was loaded onto the chip.  A sample of 10 μL of cells was injected 
immediately thereafter, followed by loading of another 20 μL of lysing agent onto the 
bed.  The valve was then switched back to “inject”, and 100 μL of the wash solution (20 
mM Tris buffer) was flowed through the chip to eliminate proteins and other potential 
nonlipid materials.  Finally, the purified lipids were eluted in selected eluent (methanol, 
isopropanol, or acetonitrile on a silica bed; chloroform/methanol, 2:1 (v/v) or 
tetrahydrofuran/methanol, 1:1 (v/v) on a C18 bed) and were collected in sample vials for 
subsequent mass spectrometry analysis.  To eliminate carry-over, the solid phase was 
flushed with methanol for 30 min at a rate of 10 μL/min between each run.   
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Figure 1-3 The microdevice setup used for extraction of lipid from bacterial cells. The flow system 
consists of a syringe pump, which is connected to an HPLC type injection valve for loading the 
lysing agent and Tris buffer to the microchip. 
 
 
1.3.4 Cell Staining and Lysis 
 
Sulfurospirillum barnesii strain SES-3 cells were kindly provided by Dr. P. Basu, 
Duquesne University.  S. barnesii is a readily available arsenate respiring bacterium with 
a simple lipidome [36, 37].  The cells were treated with a cell-labeling dye that stains 
intact cells but displays a large decrease in fluorescence when cells are completely lysed 
[38].  The dye DiO (Invitrogen Molecular Probes, Inc., Carlsbad, CA) was prepared 
according to the manufacturer’s instructions, and the prepared stock solution was stored 
at -20 °C.  To stain the cells, a 0.5 mL portion of live cells was placed in a 
microcentrifuge tube.  A volume of 1 μL of 1:100 diluted DiO stock solution was added 
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to the live cells, and the contents were vortexed for 1 min.  The final concentration of the 
dye was 0.6 M.    
A solution of washed S. barnesii strain SES-3 cells was prepared as follows.  
First, 0.5 mL of cells was placed in a 37 °C water bath for 8 min.  After heating, the tube 
was centrifuged for 5 min at 6 900g, during which a pellet was formed and the 
supernatant was subsequently removed.  The cells were then washed in 0.5 mL of 20 mM 
Tris buffer, and a pipet was used to break up the cell pellet.  The tube was vortexed for 1 
min, then centrifuged for another 5 min at 6 900g.  The supernatant was removed and 
discarded after centrifugation.  The pellet was finally resuspended in 0.5 mL of 0.15 M 
Tris buffer. 
Lysing agent was prepared by adding 20 mg of Omnipur egg white lysozyme 
(EMD Chemicals, Gibbstown, NJ) to 6 mL of 20 mM Tris HCl buffer with a pH of 7.5.  
To lyse the cells, the lysing agent was loaded onto the microchip by syringe flow using a 
Harvard PHD 2000 syringe pump at a flow rate of 10 μL/min for 24 s followed by 
loading of the stained cells for 12 s.  The lysing agent was then flowed over the bed at the 
same flow rate for another 24 s.  The loading time was calculated to take into account any 
dead volume of the column and tubing. 
In the loading and lysis steps, cells were imaged fluorescently at the inlet 
reservoir of the microchip using a Nikon Eclipse E-600 microscope with a 100 W 
mercury lamp.  A FITC-HYQ filter set (excitation bandpass filter 480 (20 nm, dichroic 
reflector 505 nm cut-on, and emission bandpass filter 535 (25 nm) was applied for the 
imaging.  The images were recorded using a RT-slider camera and a QED camera 
standalone program.  The contrast of the images was enhanced using Adobe Photoshop 
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CS4.   
 
 
1.3.5 Modified Bligh-Dyer Method and Thin Layer Chromatography 
 
In our protocol, 0.2 mL of cultured cells were mixed with 0.75 mL of 
chloroform/methanol, 1:2 (v/v) and vortexed for 1 min.  A volume of 0.25 mL of 
chloroform and 0.25 mL of deionized water containing 1% acetic acid were added into 
the mixture and vortexed for another 1min.  The solution was subsequently centrifuged at 
1300 rpm for 5 min.  The lower phase was collected with a Pasteur pipet and then 
evaporated followed by reconstitution in 0.5 mL of methanol with 10 mM NH4OH. 
Samples were introduced into the electrospray ionization-quadrupole (ESI-Q) mass 
spectrometer for lipid profiling, and the profile was compared to that obtained using the 
microchip method.   
A TLC method was used to facilitate developing a separation of the main 
phospholipids classes present in the cell membranes.  TLC was performed on silica gel 
plates, which were pretreated (full length) in a Camag horizontal developing chamber to 
remove impurities by methanol: ethyl acetate (6:4).  The plates were activated for 10 
minutes at 130
o
C.  Phospholipids, extracted according to Bligh and Dyer, were loaded to 
TLC plate at 10 mm from the edge using 10 µl capillary pipette 5 times.  500 ng/µl of 
each standard phospholipid, phosphatidylethanolamine (PE), phosphatidylinositol (PI), 
sphingomyelin (SM), and their mixture, were also applied on TLC plate.  
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The plate was developed in a developing chamber containing dichloromethane: 
ethyl acetate: acetone (80:16:4) for 70 mm to separate cholesterol, free fatty acid, and 
triglycerides from phospholipids to prevent overloading of the silica particles at the start 
position.  The plate was dried under an air stream (40
o
C) for 10 minutes.  The 
phospholipids were subsequently separated by chloroform: ethyl acetate: acetone: 
isopropanol: ethanol: water: acetic acid (30:6:6:6:16:28:6:2) elution for 55 mm.  The 
plate was dried for 5 minutes at 130
o
C and placed into the iodine staining chamber face 
down at a 45
o
 angle, with the top of the plate on the bottom of the chamber.  After 5 
minutes, the plate was removed and immediately placed face down on the bed of the 
scanner to ensure minimal evaporation of iodine.  The images were cropped and saved 
in compressed TIFF format for further analysis [39-42]. 
 
 
1.3.6 Mass Spectrometry Conditions 
 
The characterization of phospholipids from lipid extract by ESI-MS is based on 
the ability of each lipid class to acquire positive or negative charges when in solution 
under the ionization source high energy.  Lipids that do not possess inherently ionizable 
moieties can also be ionized under the conditions of ESI-MS, and as long as there is 
sufficient dipole potential for interaction with counter ions, these species can be analyzed.  
Thus under suitable conditions of sample preparation, all molecular species that exist 
among cellular lipid classes can be detected in a single run of an on-chip lipid extraction.  
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A single molecular ion with a mass-to-charge ratio (m/z) characteristic for the 
monoisotopic molecular weight is present for each molecular species.   
In order to obtain higher resolution in spectrum, an Agilent 6520 nano 
electrospray ionization quadrupole time-of-flight (nanoESI-Q-TOF) mass spectrometer 
was used for lipid extracts profiling.  Aliquots (20 μL) from loading, washing, and elution 
steps were collected during the extraction.  The lipid extracts were dried by N2 and 
resuspended in HPLC-grade methanol with 10 mM NH4OH.  Samples were introduced 
by direct infusion using a Harvard PHD 2000 syringe pump at a flow rate of 70 μL/h.  
MS only data was acquired in both positive and negative ion modes.  The following 
settings were maintained throughout the analysis: drying gas flow of 10 L/min, drying 
gas temperature of 350 °C, nebulizer pressure of 45 psi, data range of m/z 200-1000, 
acquisition rate of 1000 ms/spectrum, fragmentor voltage of 150 V, skimmer voltage of 
60 V, octopole rf voltage of 250 V, and capillary voltage of 3.5 kV.  Typically, a 1 min 
period of signal averaging in the profile mode was employed for each spectrum. 
 
 
1.3.7 Data Analysis 
 
METLIN Personal Metabolite database and LIPID MAPS database were applied 
for the identification of phospholipids species present in cell extracts.  This application 
enabled us to enter the m/z value of an unknown lipid ion or a batch of lipids and predict 
the most likely molecular species, based on internally generated lists of side-chains and 
headgroups of phospholipids.  LIPID MAPS database was set as: intensity threshold: 
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100; mass tolerance: +/- 0.01 amu; ion mode: [M+H]
 +
; sort by: molecular formula.  Six 
major phospholipid classes were detected in positive and negative ion mode: 
phosphatidylinositols (PI), phosphatidylserines (PS), phosphatidylglycerols (PG), 
phosphatidylcholines (PC), phosphatidylethanolamine (PE), and phosphatidic acid (PA). 
Additionally, the lyso variants for all of the above mentioned phospholipids (LPI, LPS, 
LPG, LPC, LPE, and LPA) and phosphatidylinositol monophosphate (PIp) were also 
detected during the process. 
 
       
1.4 Results and Discussion 
1.4.1 Overview 
 
The goal of this work was to create a simple microdevice for effective cell lysis 
followed by lipid capture, cleanup, and recovery.  A few preconditions must be met in 
order to ensure a seamless coupling of solid phase extraction and a microfluidic platform. 
First, the lysing agent must effectively lyse intact cells in the volume present in the 
microchannel.  Second, the released lipids must bind to the extraction bed successfully.  
Finally, the retained lipids must be eluted from the solid phase with high extraction 
efficiency and consistent reproducibility (recovery rate).  A typical MS-based lipidomic 
workflow is illustrated in Figure 1-4, which shows that the initial step in data analysis is 
lipid identification. 
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Figure 1-4 Workflow of lipidomics analysis in systems-level scale. 
 
 
1.4.2 Evaluation of Lysing Agent 
 
In order to consistently extract lipids from bacteria cells with high efficiency, it is 
necessary to lyse the cells completely.  Figure 1-5A depicts the bacteria cells after the 
initiation of flow of the lysing agent into the inlet port of a complete microfluidic device.  
The fluorescence signal decreased after 1 min of flow and was undetectable after 3 min 
(Figure 1-5B), which confirms the sufficient lysis of the cells.  Thus, these lysing 
conditions were applied in the subsequent experiments. 
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Figure 1-5 Fluorescence images of on-chip cell lysis under microscopy at 20× magnification. (A) 
Image taken when DIO labeled cells were flowed into the inlet irradiated with 480-560 nm light. 
(B) Image taken after flow of the lysing agent over 3 minutes. 
 
 
1.4.3 Effect of Lipid Extraction 
 
As the lysing agent for cell lysis had been chosen, it was necessary to make 
sure that released lipids successfully adsorbed to silica surfaces.  Several purification 
goals must be achieved to recover phospholipids from cells and adsorb them to the silica 
phase in a single step.  To make the purification protocol as simple and effective as 
possible, cell lysis and lipid binding to silica surfaces were accomplished using one single 
loading buffer.  Several factors are taken into account when choosing the loading buffer. 
Solutions of high ionic strength facilitate the adsorption of phospholipids on the 
stationary phase as a result of a variety of interactions.  At higher ionic strength, the 
negative potential of silica surfaces is reduced, thereby decreasing the electrostatic 
repulsion between the negatively charged phospholipid molecules and the bead surface. 
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However, high concentrations of salt reduce the water activity due to the formation of 
hydrated ions, which facilitates the dehydration of phospholipids and silica surfaces and 
drives the lipid to the extraction bed [43].  The electrostatic repulsion can be further 
reduced if the phospholipid is dissolved in a loading buffer below the pKa of the silica 
(pKa ≈ 8), due to the fact that increasing protonation of the surface silanol groups reduces 
the surface charge [44-46].  In addition, extremely acidic loading buffer conditions could 
affect the solubility of lipids and may induce precipitation, which could ultimately lead to 
a failure of the microfluidic device.  Consequently, a buffer of 20 mM Tris HCl with pH 
of 7.5 was chosen for phospholipid adsorption to silica surfaces.  
According to previous research on the physicochemical properties of silica 
materials for lipid extraction, surface properties play a critical role in the extraction of 
hundreds or even fewer cells [47, 48].  Size and shape of the particles, diameter and 
volume of the pores, and the packing and resin porosity are of major concerns to the 
overall effectiveness of phospholipid binding.  In this work, two types of silica resins, 
silica beads (100 Å, 20 μm) and C18 beads (100 Å, Luna 15 μm), were selected as the 
packing material to adsorb the phospholipids.   The microporous structure prevents the 
macromolecular proteins from going through the beads while keeping small analytes 
including polar lipids from entering and being retained. 
The performance of lipid extraction on the microchip was evaluated by extraction 
efficiency and reproducibility during the purification process.  The recovery of 
phospholipids from the device was accomplished using various elution solvents with high 
ionic strength.  Methanol, chloroform and acetonitrile were used on silica phase while 2:1 
chloroform/methanol and 1:1 tetrahydrofuran/ methanol were used on C18 phase.  An 
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electrospray ionization-quadrupole (ESI-Q) mass spectrometer (Waters ZMD MS) was 
utilized in the study of lipid species profiling.  The lipid extracts were eluted by methanol 
(Figure 1-6), acetonitrile (Figure 1-7) and isopropanol (Figure 1-8) on microchip packed 
with silica beads. 
 
 
Figure 1-6 ESI-Q MS profile of lipid extracts eluted by methanol from silica packing microchip. 
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Figure 1-7 ESI-Q MS profile of lipid extracts eluted by acetonitrile from silica packing microchip. 
 
 
Figure 1-8 ESI-Q MS profile of lipid extracts eluted by isopropanol from silica packing microchip. 
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Lipids were also extracted by 2:1 chloroform/methanol (Figure 1-9) or 1:1 
tetrahydrofuran/ methanol (Figure 1-10) on the microchip packed with C18 beeds.  A 
shift in overall mass in going from C18 to silica was observed, which indicates different 
extraction efficiency and tendency by using different eluents.  
 
 
Figure 1-9 ESI-Q MS profile of lipid extracts eluted by 2:1 chloroform/methanol from C18 packing 
microchip. 
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Figure 1-10 ESI-Q MS profile of lipid extracts eluted by 1:1 tetrahydrofuran/methanol from C18 
packing microchip. 
 
 
In contrast to loading buffer, the eluent exhibited a slightly higher back-pressure 
due to its high viscosity, which caused a drop in flow rate to 8 μL/min.  In order to 
evaluate the lipid extraction efficiency, the numbers of identified phospholipid species 
extracted from the microchip by different eluents were compared with that obtained by 
the modified Bligh-Dyer method (Figure 1-11)  
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Figure 1-11 ESI-Q MS profile of total lipid extracts by Bligh and Dyer extraction methed. 
 
 
The overall extraction efficiencies of the silica chip with different eluents were 
83.3% (methanol), 49.3% (isopropanol), and 29% (acetonitrile), respectively (Figure 1-
12).  When the phospholipids were eluted from the C18 chip by chloroform/methanol 
(2:1, v/v) or tetrahydrofuran/methanol (1:1, v/v), the on-chip extraction efficiencies were 
71.7% and 61.8% compared to that obtained using the modified Bligh-Dyer method 
(Table A-1 in Appendix I).  Thus, silica beads were selected as the packing material with 
methanol as the eluent for lipid extraction in subsequent experiments.  Lipid extracts 
from Bligh and Dyer were run through thin layer chromatography to identify the 
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component of lipid classes.  Non-phospholipids (CE, TG, FFA) were separated from 
target lipids to upper plates.  PI and PE were identified comparing to standards selected 
(data not shown).  TLC was used to prove that total lipid extraction from the cell by Bligh 
and Dyer method did extract the expected phospholipids. 
 
 
Figure 1-12 Comparison of on-chip extraction efficiencies of phospholipid using different eluents. 
Silica (black) and C18 (gray) resins were applied as packing materials. The error bars represent 
the variation of four individual experiments. Values represent mean ± S.E. of triplicate 
determinations. 
 
 
1.4.4 Reproducibility 
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Before each extraction, the silica beads were reconditioned by flushing methanol 
for 30 min, followed by another flush with 20mMTris buffer for 10min.  In a 
measurement where 10 μL of 34:2 phosphatidylcholine (PC) and 34:1 
phosphatidylinositol (PI) (Sigma-Aldrich Chemical Co., St. Louis, MO) standard mixture 
were loaded at a final concentration of 5 μM for 10 successive extractions, the average 
phospholipid recovery rate for the microchip was 55.34% and 46.12%, respectively 
(Figure 1-13).  It is shown that the reproducibility of lipid extraction from the silica bed 
decreases after the fourth run.  In order to overcome this issue, new silica beads were 
packed to the chip, and the lipid recovery rate went back to around 65% for 34:2 PC.  In 
summary, the microchip packed with fresh silica beads is capable of being reused four 
times without any loss in the lipid extraction process. 
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Figure 1-13 Phospholipid recovery rate on the microchip over ten successive extractions. 
Standard mixtures of 5 μM 34:2 PC (black) and 34:1 PI (gray) were used. Values represent mean 
± S.E. of ten successive measurements in triplicate determinations. 
 
 
1.4.5 Extraction Profile 
 
To ensure that phospholipids were eluted from cells only when the eluent was 
applied, fractions were collected and analyzed for a phospholipid elution profile during 
extraction and the results are shown in Figure 1-14.  During this extraction step, a sample 
of 10 μL cells sandwiched with 20 μL of lysing agent was loaded onto the silica bed at a 
flow rate of 10 μL/min.  After a wash with 20 mM Tris HCl buffer (100 μL, pH 7.5), 
during which any nonlipid materials were removed, the lipids were eluted in methanol.  A 
total of 18 fractions of the eluate (20 μL each) were collected at the outlet of the device 
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during each step of the extraction (cells loading/lysing, nonlipid materials washing, and 
lipids elution).  The phospholipid 34:1 PI was chosen for lipid quantification during the 
extraction process by the nanoESI Q-TOF mass spectrometer.  As shown in Figure 1-14, 
the major elution of 34:1 PI occurred in the first 80 μL of the elution phase, with 
negligible concentrations of lipid detected in other steps.  This result indicates that there 
was no significant loss of lipid during the loading and washing steps, and most of the 
extracted 34:1 PI was eluted from the first several tens of microliters.  These results are 
consistent with the fact that 34:1 PI was eluted reproducibly in the first 80 μL of the 
elution phase, which suggests that the lysing agent/loading buffer did not interfere with 
binding of the lipid to the silica bed or impact lipid recovery negatively.   
 
 
Figure 1-14 Extraction profile of 34:1 PI from the silica chip eluted by methanol. Fractions (20 µL 
in volume) were manually collected during loading, washing and elution steps. 
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1.4.6 Data Analysis 
 
In order to identify the molecular species of phospholipids from S. barnesii cells, 
the nanoESI-Q-TOF MS/ MS was applied along with “untargeted” (discovery profiling) 
approaches for lipidomics research.  The data analysis workflow consists of interrogation 
of lipid extracts data files from MS by a METLIN Personal Metabolite database and 
LIPID MAPS database.  LIPID MAPS provides a platform that has the versatility to 
quantify known individual lipid molecular species and search for novel lipids affecting 
biological systems.  With the list of possible identities significantly narrowed, 
phospholipid species were identified using a custom subset of the METLIN Database 
relevant to lipid metabolites in the mode of accurate-mass information searching.  Sample 
data files were subsequently imported in MassHunter Qualitative Analysis software 
(Analyst QS) by loading the lipid database that contains the empirical formula of each 
lipid species.  The data files were queried by each formula using a “Find by Formula” 
function, which finds and extracts all the coeluting isotopes, salt adducts, and dimers that 
belong to each empirical formula. 
Six major classes of phospholipid and their lyso variants were identified with this 
method.  Within these classes, each of the target mass identified in the profiling processes 
was searched against the METLIN database over a 10 ppm mass window.  A mass error 
window of 5 ppm was set for the empirical formula calculation.  Three major lipid 
classes, PC, PS, and PE, are detected in positive ionization mode (+ESI) [49-52], while 
 36 
four major lipid classes, PI, PS, PG, and PA, are detected in negative ionization mode (-
ESI) [53-55].  Their representative diagnostic ions are illustrated in Table 1-3.  In 
addition, the lyso variants for all these phospholipids (LPE, LPC, LPA, LPI, LPS, and 
LPG) can be detected in both modes.  Finally, the results from METLIN searches were 
incorporated into Excel spreadsheets for further interpretation. 
 
Lipid Class Diagnostic ion Ionization mode 
Phosphatidylcholine 184 Positive 
Phosphatidylethanolamine 
141 Positive 
196 Negative 
Phosphatidic acid 153 Negative 
Phosphatidylinositol 241 Negative 
Phosphatidylserine 
185 Positive 
87 Negative 
Phosphatidylglycerol 172 Negative 
Table 1-3 Diagnostic ions used for identification of major lipid classes in MS/MS 
 
A link to the LIPID MAPS database was also provided to predict possible 
phospholipids species present in the cell extracts.  This application allows for input of the 
m/z value of an unknown lipid ion or a batch of lipids to predict the most possible 
molecular species, based on internally generated lists of side-chains and head groups of 
glycerophospholipids and sphingophospholipids.  The parameters used were listed as 
follows: intensity threshold of 1000, mass tolerance of ±0.01 amu, and ion mode of [M + 
H]
+
 or [M - H]
-
. 
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Low mass peaks (below m/z 350) were assigned to free fatty acid as a result of in-
source collision-induced fragmentation.  Peaks of lyso variants for all kinds of 
phospholipids were in the range of m/z 350-600.  Most of the major phospholipid classes 
(PE, PC, PG, PS, PA, and PI) fell in the range between m/z 600 and 1000, which 
consisted of about 70% (about 380 peak envelopes) of the MS peaks (Figure 1-15A and 
15B).  As shown in Figure 1-15C and 15E, 34:2 PC was detected with [M + H]
+
 = 
758.561, and a characteristic phosphocholine headgroup peak at m/z 184.073 was shown 
in the MS/MS spectrum by applying 20 eV on the extracted parent ion.  Relatively small 
peaks of lysophosphotidylcholines ([LPC + H]
+
 and [LPC - H2O + H]
+
 ) correspond to 
the loss of one fatty acyl substitute as a ketene [M - R2CH=C=O]
+
.  In Figure 1-15D and 
15F, the peak of m/z 835.585 was assigned to 34:1 PI and its parent ion was extracted for 
fragmentation at 45 eV.  Lysophosphotidylinositols ([LPI - H]
-
 and [LPI - H2O - H]
-
), 
lysophosphatidic acids ([LPA - H2O - H]
-
), and the characteristic headgroup fragments 
including glycerophosphoinositols ([GPI - H2O - H]
-
 and [GPI - 2H2O - H]
-
), fatty acid 
([FA - H]
-
), inositolphosphate ([IP - H2O - H]
-
 and [IP - 2H2O - H]
-
), and 
glycerophosphate ([GP - H2O - H]
-
) were observed for the specific PIs identification. 
Fragmentation of these phospholipid species in both ionization modes yielded a wealth of 
structural information.  In each case, the lipid identification process was aided by 
headgroup fragmentation, lyso-lipid formation, and fatty acid fragments.  With the use of 
the LIPID MAPS mass prediction tool, many possible phospholipids species and their 
structures (double bonds, carbon numbers of fatty acyl chains, and head groups) were 
determined.  Table A-2 in the Appendix II shows a summary of the proposed 
phospholipids based on METLIN database [56] and LIPID MAPS database matches of 
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the measured mass of the parent ions with their theoretical mass over complementary 
approach for identification of phospholipid isomers.  
 
 
Figure 1-15 Mass spectra of phospholipid extracts from S. barnesii cells eluted from silica bed of 
microchip by methanol. Six major lipid classes were detected in positive (A) and negative (B) 
ionization modes, e.g. 34:2 PC (C) and 34:1 PI (D) were detected and their structures were 
identified with corresponding tandem mass spectra (E, F). 
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Empirical formulae prediction software (Analyst QS) was used to support the 
stages of data processing.  To the information of the mass to charge ratios of molecular 
ions provided by the MS spectrum data, the criteria for filtering the most possible ions 
were as follows: possible elements C, H, P, O; adducts [M+H]
-
, [M+NH4]
+
, [M-H]
-
; mass 
tolerance 10 ppm.  Within 10 ppm in mass error window, empirical formulae of the 
analytes were independently matched to the predicted values.  Over 170 of identified 
phospholipids and lysophospholipids with 12-44 total carbons were comprised by peaks 
that matched the criteria.  Some peaks had more than one possible lipid species that 
matched the empirical formulae in the same error score.  These peaks were identified by 
the corresponding fragmentation patterns using the tandem mass spectrometry in order to 
obtain detailed information of the molecular ions.  With this “untargeted” lipidomics 
approach, as many as 173 phospholipid species were identified from on-chip bacterial 
cell extracts (See Appendix II).   
 
 
1.5 Conclusions 
 
A microscale solid phase extraction method was developed for the extraction of 
glycerophospholipids from bacteria cells with integration to analysis by small scale 
lipidomics.  A buffer solution of 20 mM Tris HCl at pH 7.5 containing 20 mg of omnipur 
egg white lysozyme was demonstrated to work effectively as a lysing agent for 
Sulfurospirillum barnesii strain SES-3 cells on microfluidic devices.  Among different 
types of stationary phase and elution solvent for lipid capture tested, the best extraction 
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was obtained by using a silica phase with methanol as the eluent with the efficiency of 
83.3% (Figure 1-16).  Lipids purified with the developed method were suitable for 
subsequent lipidomics analysis and compared favorably with lipids extracted by a 
commonly utilized Bligh-Dyer method.  By incorporation of both fast and robust peak 
finding algorithms and visualization software, many phospholipids were found to have 
matches to the METLIN and LIPID MAPS databases.  In summary, this work presents a 
highly efficient method for microchip based solid phase extraction for use with 
microscale lipidomics. 
 
 
Figure 1-16 Scheme of on-chip lipid extraction with lipidomics study by Q-TOF MS. 
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Chapter 2 
 
 
Analysis of Glycerophosphoinositol Uptake in Candida 
albicans by Liquid Chromatography-Electrospray 
Ionization Tandem Mass Spectrometry1 
 
 
 
 
 
 
 
1
The application of the approach described in this Chapter has contributed to the 
following publication: 
Bishop, A. C.; Sun, T.; Johnson, M. E.; Bruno, V. M.; Patton-Vogt, J. Robust utilization 
of phospholipase-generated metabolites, glycerophosphodiesters, by Candida albicans: 
Role of the CaGit1 permease, Eukaryotic Cell, 2011, 10 (12), 1618-27. 
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2.1 Abstract 
 
The phosphatidylinositol (PI) metabolite, glycerolphosphoinositol (GroPIns), 
which results from phospholipase B-mediated cleavage of phosphatidylinositol, exits and 
enters the yeast, Saccharomyces cerevisiae.  In S. cerevisiae, GroPIns is transported 
across the plasma membrane via a transport protein encoded by the GIT1 gene.  GroPIns 
transport has not been addressed in the pathogenic yeast, Candida albicans, but the C. 
albicans genome has four potential GIT1 homologs.  In order to investigate and identify 
the role of CaGIT1 as a GroPIns permease in C. albicans, a liquid chromatography- 
tandem mass spectrometry based method (hydrophilic interaction liquid chromatography-
MS/MS
 
rather than reverse phase liquid chromatography-MS/MS) for quantification of 
GroPIns is described.  GroPIns is eluted at retention time of 13.06 ± 0.15 min with total 
run time of 15 min.  Quantification was performed by generation of an external 
calibration curve.  The developed approach was employed to monitor the levels of 
GroPIns in the medium.  Our results show that while a wild type C. albicans strain 
transports exogenously supplied GroPIns into the cell, a strain lacking the CaGit1 
permease does not. 
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2.2 Introduction 
 
Phosphatidylinositol, which accounts for up to approximately 10% of membrane 
phospholipids, is widely distributed among the different cellular membranes.  
Phosphatidylinositol has been reported to be degraded by at least four distinct routes [1, 
2].  The fatty acid esterified at the sn-1 and the sn-2 positions of the glycerol moiety are 
removed by phospholipase A1 and phospholipase A2, respectively, thus providing an 
important source of fatty acid.  Phospholipase B refers to an enzyme that is able to 
hydrolyze the fatty acyl ester bond at both the sn-1 and sn-2 positions on glycerol.  By far 
the most widely studied pathway for metabolism of phosphatidylinositol involves 
cleavage of the diacylglycerol-phosphate bond by phsopholipase C.  Alternatively, 
phosphatidylinositol appears to be hydrolyzed by cleavage of the inositol-phosphate bond 
by phospholipase D to phosphatide and inositol.  
The extracellular glycerophosphodiesters, such as glycerophosphoinositol 
(GroPIns), are the products resulting from hydrolysis of both fatty acid chains of 
phospholipids via phospholipase B-mediated deacylation.  Most fungal cells including 
Candida albicans contain multiple phospholipase B (PLB)-encoding genes that have 
deacylation activity [3].  Although PLBs play a potential role as virulence factors, the 
metabolic fate and function of the products of PLB turnover, the glycerophosphodiesters, 
remain an open question [4-8].  This stands in stark contrast to our understanding of the 
inositol-phosphates resulting from phospholipase C-mediated cleavage, for which 
numerous kinases and phosphatases have been identified, and many metabolic 
conversions clearly documented [9].  In addition, not all of the cell’s 
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glycerophosphodiesters appear to be produced via C. albicans PLB activity and there is 
growing evidence that this metabolic segregation, especially GroPIns and GroCho, may 
be achieved by the occurrence of host phospholipase activity in organism [10-19]. 
In S. cerevisiae, GroPIns is transported into the cell via the transport protein, 
ScGit1, encoded by the GIT1 gene.  Four open reading frames (orfs) in C. albicans, 
CaGIT1-4 contain significant sequence homology to ScGIT1 [20].  ScGit1 and CaGit1-4 
are between 400-600 amino acids in length and contain either 12 or 14 membrane 
spanning segments [21].  The C. albicans genome contains five PHS (phosphate: H
+
 
symporter) family member: CaGit1-4 and Pho84, the homolog of the S. cerevisiae high 
affinity phosphate transporter.  Notably, none of these family members has been 
characterized in C. albicans. 
The method described here was developed to accurately determine the occurance 
of GroPIns at nanogram levels or below in the media of C. albicans.  In a biological 
matrix, analytes can have different sizes, charges, polarities and hydrophobicities.  
Chromatography techniques provide control of separation through changes in the mobile-
phase solvent content, the ionic strength, the pH, and the salt additives.  Options for 
optimal separations can be achieved through chromatographic mode, such as normal-
phase liquid chromatography (NPLC), reversed-phase liquid chromatography (RPLC), 
hydrophilic interaction liquid chromatography (HILIC), and ion-exchange liquid 
chromatography (IEX-LC).  Approximately 80-90% of all HPLC analytical separations 
apply RPLC as the separation mode.  However, small polar compounds are often very 
challenging to biological analysis.  It is difficult to analyze polar analytes by RPLC due 
to the lack of sufficient retention ability on reverse-phase columns.  Although NPLC and 
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IEX-LC can retain polar and charged compounds, their organic solvent contents in the 
mobile phase have either high ionic strength or are not amenable to the electrospray 
ionization environment in mass spectrometry.  Moreover, ion pair separation of both acid 
and a base in the same analysis is difficult.   
HILIC is a viable complementary method to RPLC, NPLC, and IEX-LC and is 
widely used for the separation of biologically active polar substances, such as amino 
acids, peptides, carbohydrates, oligosaccharides, etc.  The stationary phase of HILIC 
column is composed of polar materials such as silica, amino or mixed mode, and its 
mobile phase is mainly organic with aqueous solvent.  Its mechanism of separation is 
based on the ability of a polar analyte to partition into and out of adsorbed water and the 
addition of a charged polar analyte to undergo cation exchange with charged silanol 
groups.  The combination of these mechanism results in enhanced polar retention while 
lack of either of the mechanisms results in no polar retention [22-25].  Table 2-1 
summaries the different methods for GroPIns separation.  The separations of GroPIns 
have mainly been done on anion-exchange columns [26, 27].  A microchip based 
separation of phosphoinositides by micellar electrokinetic capillary chromatography 
method was reported [28].  An amino-phase column was also applied to separate GroPIns 
and other inositol phosphates using an acetate buffer in the mobile phase [29].  The above 
techniques have the non-negligible disadvantage of being a multi-step procedure in which 
the isotopic equilibrium of radiolabelled products is difficult to achieve.  Recently, a LC-
MS/MS method using a β-cyclodextrin-bonded column was described for the quantitative 
analysis of internal GroPIns in rat cell lines, but extracellular GroPIns was not included 
in this method [30].  Another study used normal phase LC-MS to quantitate several 
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water-soluble metabolites, including GroPIns and GroPCho, from rat brain tissue [31].   
Our study differs from previous studies in that we use HILIC chromatography coupled 
with MS/MS to detect GriPIns in the extracellular medium which has a high 
concentration of other small molecules, including free phosphate. 
 
Method Analyte Sample Detector Reference 
Anion-Exchange 
column with Cation-
Exchange column 
GroPCho, 
GroPEth 
Hamster 
ovary cells 
Liquid 
Scintillation 
Counting 
[27] 
Amino-Normal phase 
column 
GroPIns, 
Inositol 
phosphates 
Human 
platelets 
Liquid 
Scintillation 
Counting 
[29] 
Phenomenex NH2 
Normal Phase 
column 
GroPIns, 
GroPCho 
Mice brain 
tissue 
Q-TOF MS [30] 
Nucleodex β-OH 
Silica column 
GroPIns 
Mice cell 
lines 
Triple 
Quadrupole 
MS 
[31] 
Waters Xbridge 
HILIC column 
GroPIns, 
GroPCho, 
GroP, Inositol, 
Choline 
Yeast 
extracellular 
medium 
Triple 
Quadrupole 
MS 
Patton-
Vogt et al 
(accepted) 
Table 2-1 Summary of methods for separating and detecting GroPIns and GroPCho. 
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HILIC overcomes the shortcomings of some of the other retention mechanisms 
for extremely polar compound analysis.  It retains highly polar analytes that would not be 
retained by RPLC, and using a highly organic mobile phase promotes enhanced ESI-MS 
response.  In the tandem mass spectrometer, the analyte, GroPIns was dissociated by 
collision gas to produce various product ions that could be monitored at the same time.  
Liquid chromatography combined with tandem mass spectrometric detection was the 
preferred method for quantitative analysis due to its intrinsic selectivity, sensitivity, and 
speed in “omics” studies [33-36].  The expected fragmentation patterns of GroPIns are 
shown in Figure 2-1.  Although there are other methods available to study GroPIns, the 
published methods mainly include radioactive analysis and have not added the absolute 
quantification of the metabolites in the extracellular medium of a cell culture [37-39].  
Our aim was to develop a novel HILIC-MS/MS method for quantification of GroPIns in 
the extracellular medium of Candida albicans to monitor its uptake as a function of 
growth. 
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Figure 2-1 Expected fragmentation patterns of GroPIns by tandem mass spectrometry. 
 
 
2.3 Materials and Methods 
2.3.1 Reagents 
 
The methanol and acetonitrile used for the LC-MS/MS analysis were Optima 
grade from either Thermo Fisher Scientific (Pittsburgh, PA) or J.T. Baker (Phillipsburgh, 
NJ).  Distilled water was deionized with Barnstead Nanopure water system (Dubuque, 
IA).  The water was filtered with 0.22 μm Nylon membrane filters from either Millipore 
(Billerica, MA) or Whatman International (Maidstone, England) prior to use.  The mobile 
phase for the HPLC analysis contained ammonium acetate (99% pure) from Thermo 
Fisher Scientific in both acetonitrile and water.  These solutions were made up fresh each 
day and sonicated for 15 min in a 2210 Branson Ultrasonic cleaner (Danbury, CT) to mix 
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and degas before use.  Glycerophosphoinositol (L-α-glycerophospho-D-myo-inositol) 
was from Sigma-Aldrich (St. Louis, MO).   
 
 
2.3.2 Strains, Media and Culture Conditions 
 
A wild type C. albicans strain DAY185 (ura3Δ::λimm434/ura3Δ::λimm434 
pARG4::URA3::arg4::hisG/arg4::hisG pHIS1::his1::hisG/his1::hisG) was used in this 
study.  The strain in which the CaGIT1 gene was deleted was constructed in strain 
DAY185 to produce git1::UAU1/git1::URA3 (JPV484).  For insertional 
complementation, plasmid pDDB78GIT1 was linearized and transformed into JPV484 to 
produce JPV512 (git1::UAU1/git1::URA3 + pDDB78GIT1).  Empty plasmid pDDB78 
was also linearized and transformed into JPV484 to produce JPV526 
(git1::UAU1/git1::URA3 + pDDB78).  Insertional complementation or reintegration 
delivers the GIT1 gene back into the mutant strain to test for reoccurrence of the wild 
type transport function.  The strains were grown aerobically over night at either 30°C or 
37°C with shaking in low phosphate (Pi) yeast nitrogen base (YNB) media.  Growth was 
monitored by measuring the optical density at 600 nm (OD600) on a Biomate 3 Thermo 
Spectronic spectrophotometer.  Low Pi media were made by replacing the KH2PO4 (1 
gm/liter) in YNB media with KCl (1gm/liter) and adding KH2PO4 to 0.2 mM.   The 
cultures to be analyzed by MS grew in medium lacking KH2PO4 that contained 200 μM 
(≈ 67 μg/mL) GroPIns.  Immediately after inoculation, 1 mL of the samples were 
removed in duplicate to obtain T=0 time point.  Once the cultures were started, samples 
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were taken at T=6 hours and T=24 hours.  At each time point, 1 mL of the cultures was 
removed, centrifuged to pellet the cells, and the supernatant filtered through the 0.22 μm 
filters. 
 
 
2.3.3 Standards and Sample Preparation 
 
The primary solution of glycerophosphoinositol (13.4 mM) was diluted in water 
to obtain aliquots of the standard compound at the concentration of 2 mM as stock 
solutions.  A working standard solution of GroPIns in 100 μg/mL was prepared from the 
stock solution by dilution in water.  The working standard solution was further serially 
diluted in water to obtain eight calibration standard solutions of 2.5, 5, 10, 50, 100, 500, 
1000 and 10000 ng/mL (approximately 7.5-30000 nM). 
For the media samples from the above conditions, culture aliquots were 
centrifuged at 3000 rpm for 5 min, and the resulting supernatant was filtered.  250 μL of 
each media sample was then transferred into centrifuge tube and was diluted with 5 fold 
volume of methanol/water, 90:10 (v/v) for centrifugation at 10,000 rpm for 5 min.  The 
supernatant was collected and dried under a stream of nitrogen.  The residue was 
resuspended in 250 μL of acetonitrile/methanol, 3:1 (v/v).  Because the calibration curve 
ranges over 2.5-10000 ng/mL (approximately 7.5-30000 nM) and 200 μM GroPIns was 
in the media, was diluted the analyte in 1:100 fold volumes prior to analysis.  Typically, 
an injection volume of 10 μL was used and each sample was run in triplicate. 
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2.3.4 Equipment and Experimental Parameters 
 
The liquid chromatography with tandem mass spectrometry system (LC-MS/MS) 
was composed of an Agilent 1200 Rapid Resolution LC system and an Agilent 6440 
Triple Quadrupole Mass Spectrometer (Santa Clara, CA).  The Mass Hunter software 
package was used for the acquisition and processing of data.  Quantification was 
performed using Qualitative Analysis B1.0.82.2 as implemented in the Mass Hunter 
software. 
Electrospray ionization-tandem mass spectrometry (ESI-MS/MS) for 
characterization, identification as well as quantification was performed in positive and 
negative mode using product ion scan (PIS) and multiple-reaction monitoring (MRM) 
respectively with a triple quadrupole mass spectrometer.  PIS is a scan mode in which all 
product ions fragmented from the selected molecular ion are detected in one run.  MRM 
was used to monitor the mass to charge ratios corresponding to the selected precursor and 
product ions of interest; the program was set up to monitor several targeted ions at 
different time segments in one run.  The targeted ion dissociation pathway (Figure 2-2)  
 
 
Figure 2-2 Scheme of collision induced dissociation of ions in triple quadrupole mass 
spectrometer. 
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for the above scan modes was optimized with regard to collision energy to minimize 
variations in relative ion abundance due to differences in rates of dissociation.  The 
capillary voltage was maintained at 3.0 kV.  The drying gas temperature was 300 °C and 
the sheath gas temperature was 325 °C.  The drying gas flow rate was set to 4 liters/min, 
and the nebulizer pressure was 50 psi.  The mass spectrum was acquired from m/z 50-
1000 with the acquisition time same as the chromatography.  The fragmentor voltage and 
collision energy were optimized from 10-150 V and 0-100 eV.  The optimal value of the 
fragmentor voltage was manually adjusted to 90 V.  The collision energy was optimized 
to be 35 eV.  The dwell time was set to be 200 ms for GroPIns. 
The LC system, consisting of an Agilent binary pump and an Agilent high-
performance autosampler, was used to provide the mobile phase and to inject samples.  
For separation, a 5 μm XBridge column (150 x 4.60 mm, Waters, Milford, MA) was used 
for hydrophilic interaction liquid chromatography (HILIC).  The chromatography was 
performed in isocratic elution at a flow rate of 0.5 mL/min when the mobile phase was 
acetonitrile/water, 50:50 (v/v) with 10 mM ammonium acetate at pH 7.19.  The relative 
concentration of GroPIns in the media was selectively measured by multiple-reaction 
monitoring and calculated by normalizing its peak area to the peak area of the relevant 
external standards on calibration curve.  All separations were carried out at the room 
temperature (25 °C). 
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2.4 Results and Discussion 
2.4.1 Tandem Mass Spectrometry Optimization 
 
In order to obtain lower detection limit of the analyte without compromising the 
reliability of this method, a high selective MS/MS strategy rather than traditional 
approaches such as UV detection was employed to ensure the specificity of detection.    
The following conditions were applied for optimization experiments unless otherwise 
noted.  10 μL of 1000 ng/mL GroPIns was loaded onto the column.  A 20 min isocratic 
elution was applied where the column was equilibrated in 50:50 acetonitrile/water before 
each injection.  After elution, the mobile phase was ramped linearly to 90:10 
acetonitrile/water and was held over 10 min before returning to the initial conditions (5 
min ramp).  The mobile phase was then held at the initial conditions for 10 min before 
doing the next injection.  Ammonium acetate (10 mM) was in both the acetonitrile and 
the water.  The most relevant parameters in mass spectrometer to optimize are the 
capillary voltage, source temperature and drying gas flow.  The starting ESI-MS 
parameters were as follows: capillary voltage 1.5 kV, drying gas temperature 100 °C, and 
drying gas flow 2 liters/min.  A high pressure liquid nitrogen dewar was used as the 
nitrogen gas source.  Once one of the above parameters had been optimized, its setting 
was applied to optimize the other MS parameters in subsequent experiments.  For these 
experiments, the mass to charge ratio corresponding to the GroPIns being analyzed was 
monitored throughout the analysis. 
The capillary voltage is used at the entrance of the capillary and it is relative to 
the nebulizer and spray chamber that are at ground potential.  In order to optimize the 
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setting for the capillary voltage, the rest of the MS parameters were held constant.  The 
capillary voltage was varied from 1.5 to 3.5kV.  Analyte at 1000 ng/mL (≈ 3 μM) was 
injected in triplicate at each voltage setting.  The values of capillary voltage are slightly 
different in positive and in negative ionization mode.  The results in Figure 2-3 indicate 
that a capillary voltage of 3.0 kV gave the largest signal as the optimum value. 
 
 
Figure 2-3 Resulting peak intensities from injecting 1000 ng/mL (≈ 3 μM) of GroPIns into the 
mass spectrometer while varying the capillary voltage setting.  Results are the average of three 
injections with the standard deviation. 
 
A series of injections were conducted where all the parameters were held constant 
except for the temperature of drying gas varying from 100 to 300 °C. Three replicates of 
injections were done at each temperature setting.  Results from varying the temperature 
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are shown in Figure 2-4 that signal intensity increased with increasing drying gas 
temperature.  By comparing at the intensities, it was determined that 300 °C was the 
optimal setting for the ESI source. 
 
 
Figure 2-4 Resulting peak intensities from injecting 1000 ng/mL of GroPIns into the mass 
spectrometer while varying the drying gas temperature setting.  Results are the average of three 
injections with the standard deviation. 
 
An experiment was performed to optimize the drying gas flow; all the parameters 
were held constant except for the drying gas flow.  Three injections of 1000 ng/mL 
analyte were done at each gas flow setting.  The results are shown in Figure 2-5.  This 
experiment shows that the optimal drying gas flow setting was 4 liters/min.  With these 
conditions the analyte was detected by multiple reaction monitoring (MRM). 
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Figure 2-5 Resulting peak intensities from injecting 1000 ng/mL of GroPIns into the mass 
spectrometer while varying the drying gas flow setting.  Results are the average of three 
injections with the standard deviation. 
 
The nebulizer pressure was optimized by varying the setting from 30 to 50 psi, 
while the other MS parameters were held constant.  GroPIns (1000ng/mL) was injected in 
triplicate at each pressure setting.  The results are shown in Figure 2-6.  The experiment 
shows that the optimal nebulizer pressure setting was 50 psi and to some extend was flow 
dependent. 
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Figure 2-6 Resulting peak intensities from injecting 1000 ng/mL of GroPIns into the mass 
spectrometer while varying the nebulizer pressure setting.  Results are the average of three 
injections with the standard deviation. 
 
In order to assess the usefulness of ESI-MRM-MS/MS techniques for GroPIns 
analysis, experiments were first conducted to establish the most efficient transition for 
MRM.  Electrospray ionization mass spectrometry in positive (+ESI) and negative (-ESI) 
modes was performed for selective and sensitive detection.  Full scan spectra were 
acquired over the mass to charge ratio range of 50-1000.  The precursor ion of GroPIns 
([M-H]
-
) was detected at m/z 333.0 in –ESI (Figure 2-7). 
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Figure 2-7 Mass spectrum of the GroPIns in negative mode with total ion scan.  GroPIns at 1000 
ng/mL was injected. 
 
To investigate the fragmentation of the analyte, product ion scan spectra were 
acquired over the m/z range of 50-1000 for GroPIns (Figure 2-8).  The most intense 
fragment for GroPIns was selected for MRM analysis quantification with the following 
parameters: m/z 333.0 → 153.0 for GroPIns ([M-Inositol-H]-), with a screen of 
corresponding standards at 1000 ng/mL.  To further improve MRM conditions, the effect 
of fragmentor and collision energies over a range of different values were investigated by 
separate loop injections with no column connected for best response of the most intense 
precursor and product ions, respectively.  The fragmentor voltage affects the transmission 
and fragmentation of precursor ions.  It helps the ions traverse the relatively high pressure 
area between the exit of the capillary and skimmer.  The maximum structural information 
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is achieved at higher voltage values.  The analyte was first injected in the mobile phase 
(50:50 acetonitrile/water with 10 mM ammonium acetate) and MS spectra were acquired 
with a total cycle time of 500 ms and a dwell time of 200 ms.   
 
 
Figure 2-8 Tandem mass spectrum of the GroPIns by product ion scan in negative mode.  1000 
ng/mL of GroPIns was injected. 
 
With the above settings of total cycle time and dwell time, an accurate evaluation 
of a wide range of fragmentor voltage (10-150 V) in steps of 20 V for the studied analyte 
were performed.  Three injections of 1000 ng/mL GroPIns was done at each voltage 
setting.  The fragmentor voltage was optimized for best response of the precursor ion of 
GroPIns, and the optimal fragmentor voltage was transferred to an MRM method for the 
particular analyte (Figure 2-9).  While the optimal fragmentor voltage was determined at 
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90 V, values for collision energy varied for the studied analyte and needed to be analyzed 
as well.   
 
 
Figure 2-9 Resulting peak intensities from injecting 1000 ng/mL of GroPIns into the mass 
spectrometer while varying the fragmentor voltage setting.  Results are the average of three 
injections with the standard deviation. 
 
A second injection was made to optimize the collision energy.  Since different 
precursor ions have different collision stabilities, good product ion yields are achieved 
with minimum losses in the overall ion current.  The precursor ion was transmitted 
through the first quadrupole (Q1) into the collision cell (Q2), fragmented and 
corresponding fragments were monitored through third quadrupole (Q3).  The product 
ion spectra were acquired at different collision energies ranging from 0 to 100 eV in steps 
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of 10 eV.  The collision energy was evaluated for best response of the most intense 
product ion.  As shown in Figure 2-10, the intensities of the precursor ions of the analyte 
decreased when the collision energy increased.  At the meantime, the signals of its 
product ions increased at first and then decreased.  The optimal collision energy was 
selected and also transferred to the MRM.  This process for optimization was repeated for 
GroPIns and the MRM conditions were stored before sample acquisition. 
 
 
Figure 2-10 Resulting peak intensities from injecting 1000 ng/mL of GroPIns into the mass 
spectrometer while varying the collision energy setting.  Results are the average of three 
injections with the standard deviation. 
 
The optimized MS parameters for GroPIns detection were as follows: capillary 
voltage 3.0 kV, fragmentor voltage 90 V, collision energy 35 eV, drying gas temperature 
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300 °C, sheath gas temperature 325 °C, drying gas flow 4 liters/min, and the nebulizer 
pressure 50 psi.  More analytes were added once the MS parameters had been optimized 
in order to evaluate the separation conditions on the HILIC column. 
 
 
2.4.2 Liquid Chromatography Optimization 
 
Chromatographic conditions, especially composition and nature of the mobile 
phase is crucial for LC separation as this has significant impact on retention time of the 
analyte, peak shapes, sensitivity and therefore on the overall separation efficiency.    Base 
on literature survey water was selected as the strong solvent that is more polar than 
acetonitrile to elute polar analytes as the polarity of the mobile phase was increased by 
increasing the percentage of water.  Analysis of analytes was initiated under isocratic 
conditions with an aim to develop a simple separation process with a short time.  
Separation was optimized using various combinations of mobile phase between water and 
acetonitrile.  Unless otherwise noted, the optimized MS/MS parameters were applied.   
According to the manufacture’s instruction, the new column was at first flushed 
for 50 column volumes (125 mL) of 50:50 acetonitrile/water (v/v) with 10 mM 
ammonium acetate.  The column was then equilibrated with 20 column volumes (50 mL) 
of initial mobile phase conditions prior to making first injection.  Other conditions were 
also considered for best results.  At least 5% water was maintained in the mobile phase to 
ensure that column particle is always hydrated, which could greatly reduce the column 
equilibration time and thus ensure stable retention times.  For best reproducibility, a 
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blank sample at the beginning of each sample set was injected.  Additionally when using 
an autosampler, a needle wash step with acetonitrile was incorporated. 
Mobile phase combination with acetonitrile: water was performed with different 
ratios (90:10, 80:20, 70:30, 50:40, 50:50 v/v) in isocratic mode.  The initial elution was 
20 min long with constant flow rate at 0.5 mL/min and after that the column was 
equilibrated in 90:10 acetonitrile/water for 10 min.  The mobile phase was then ramped 
linearly to the initial conditions over 5 min and was held at the initial conditions for 10 
min before doing the next injection.  Ammonium acetate (10 mM) was in both the 
acetonitrile and the water.  Figure 2-11 shows the retention time increased as the 
composition of acetonitrile in the mobile phase increased.  As more acetonitrile was 
added to the mobile phase, the elution time for GroPIns was slowed down.  In other 
words, by adding more water to the initial conditions (50:50 acetonitrile/water) the peak 
was obtained at retention time of 13.06 ± 0.15 min for GroPIns with total run time of 20 
min (Figure 2-12). 
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Figure 2-11 Changes of the retention time of GroPIns on the XBridge HILIC column while varying 
the composition of acetonitrile in the mobile phase.  Results are the average of three injections 
with the standard deviation. 
 
 
Figure 2-12 LC-MS/MS separation and detection of GroPIns.  10 μL of the analyte at 1000 ng/mL 
was injected.  m/z 333.0 → 153.0 for GroPIns was monitored in MRM mode. 
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In order to evaluate the effect of buffer in the mobile phase, injections of the 
GroPIns at 1000 ng/mL were conducted in triplicate for the varying concentrations of 
ammonium acetate (2.5, 5, 7.5, 10, 15 and 20 mM) in the mobile phase.  The 
concentration of ammonium acetate had to be optimized to improve the ionization of the 
metabolites in the ESI-MS/MS source.  For these experiments, the peak areas of GroPIns 
were monitored.  Figure 2-13 shows the resulting peak areas as the concentration of 
ammonium acetate was changed for the analyte.  The experiments conclude that 10 mM 
ammonium acetate in the mobile phase gave the best ionization efficiency of the analyte 
when using ESI source.  The mobile phase was required to be prepared daily to prevent 
the degradation of the buffer. 
 
 
Figure 2-13 Resulting peak areas from injecting 1000 ng/mL of GroPIns on the XBridge HILIC 
column while varying concentration of ammonium acetate in the mobile phase.  Results are the 
average of three injections with the standard deviation. 
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After the buffer in the mobile phase had been optimized, the detection limit was 
investigated using 10 mM ammonium acetate in the mobile phase.  The isocratic elution 
was the same as above with the flow rate of 0.5 mL/min directed into the MS.  A series of 
injections were conducted, varying the concentrations of GroPIns loaded over two orders 
of magnitude.  Representative chromatograms at the lowest standard injected are 
presented in Figure 2-14.  The results indicate that the detection limit for GroPIns was 
generally 2.5 ng/mL (≈ 7.5 nM) when using this method.  Adequate sensitivity was 
observed for the lowest calibration standard.  From running these experiments, it was 
shown that the cleanness of the capillary, the chamber vacuum seal, and the gas flow 
affected the ionization of the lipid metabolites.  It was also important for the mobile 
phase with ammonium acetate to be prepared daily to prevent the buffer from degrading. 
 
 
 74 
 
Figure 2-14 LC-MS/MS separation and detection of GroPIns.  10 μL of the analyte from 2.5 to 
10000 ng/mL was injected.  Eight chromatograms are shown where the same isocratic elution 
was used, but the concentration of the analyte was varied. 
 
 
2.4.3 Method Performance 
 
Quantification was performed by comparison of the analyte peak area versus an 
external calibration curve.  The external calibration curves were generated by using eight 
calibration standards with different concentrations ranging from 2.5 to 10000 ng/mL.  
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The calibration curve standards were prepared in three replicates for analysis.   The 
results were fitted to least-squares linear regression analysis.  Figure 2-15 shows that the 
analyte has good linearity.  Correlation coefficient of the calibration curves for GroPIns is 
0.9962. 
 
 
Figure 2-15 Calibration curve of the log of the average peak area of GroPIns standard versus the 
log of the corresponding concentration (ng/mL). 
 
In order to evaluate the reproducibility of the results from run to run, 10 
successive injections of GroPIns at 1000 ng/mL were conducted on one day.  Results are 
shown in Figure 2-16.  The coefficient of variation (relative standard deviation) in the 
peak was calculated to be 3.1% for GroPIns. 
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Figure 2-16 Plot of the peak areas from GroPIns over the course of 10 successive injections. 
 
The extraction recovery of the analyte was evaluated by comparing the peak areas 
of medium spiked with standards at the concentrations of 500 and 1000 ng/mL in three 
replicates to those of blank medium extracts spiked with standards at equivalent 
concentrations after a single step liquid-liquid extraction.  The mean extraction recovery 
was 82.3% for GroPIns.  No significant degradation occurred under experimental 
conditions.  These results indicate the adequate reliability and reproducibility of this 
method within the analytical range. 
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2.4.4 Determination of GroPIns Uptake in Candida albicans 
 
The developed LC-MS/MS method was employed to monitor the levels of 
GroPIns in the medium as a function of growth in Candida albicans in order to obtain 
evidence for the transport of GroPIns across the plasma membrane.  A wild type strain 
DAY185 (JPV484), a homozygous insertional mutant of CaGIT1 (JPV526), and a 
homozygous insertional mutant bearing reintegrated CaGIT1 (JPV512) were grown over 
24 hours.  1 mL of media samples from each strain were taken in triplicate during the 
culture processes at T=0, 6 and 24 hours.  Samples were prepared as described in section 
2.2.3 and were analyzed using the optimized LC-MS/MS method.  We first monitored the 
culture media spiked with 200 μM GroPIns to get a zero time reading and again after 6 
and 24 hours of growth, at which points the GroPIns remaining in the media were 
monitored (Figure 2-17).  A decrease in GroPIns levels in wild type strain (85.17 ± 0.93 
μM at 6 hours and 1.3± 0.01 μM at 24 hours) and a decrease in GroPIns levels in 
homozygous insertion mutant bearing a reintegrated copy of CaGIT1 (125.5 ± 1.05 μM at 
6 hours and 1.3 ± 0.01 μM at 24 hours) were observed in Figure 2-17.  In contrast, there 
was no decrease in the GroPIns peak for the homozygous git1-/git1- mutant (162.33 ± 
0.96 μM at 6 hours and 178.43 ± 1.50 μM at 24 hours).  The fact that the levels of 
GroPIns in the medium decreased or remained the same depending on the presence of the 
CaGIT1 gene indicates that the depletion of GroPIns levels from the medium is 
dependent upon CaGIT1. 
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Figure 2-17 Determination of GroPIns concentrations from extracellular media of Candida 
albicans in wild type cells, a homozygous insertional mutant of CaGIT1 (git1-/- +pDDB78), and a 
homozygous insertional mutant bearing reintegrated CaGIT1 (git1-/- +pDDB78GIT) after 0, 6, and 
24 hours.  Because the analytes were diluted in 1:100 fold volumes before injection, the 
concentrations of GroPIns in the figure were calculated by multiplying the values detected in the 
MS by 100.  Values represent mean ± S.E. of triplicate determinations. 
 
 
2.5 Conclusions 
 
A new chromatographic method was developed for analyzing a small polar lipid-
related metabolite, glycerophosphoinositol, in extracellular medium of C. albicans.  The 
developed method has high reproducibility, a low limit of detection, and high selectivity.  
It requires standard instrumentation with an isocratic HPLC system and a HILIC column 
which is readily adapted to tandem mass spectrometry detection.  The time for a single 
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run analysis is less than 15 min.  The analysis time could be reduced through automation 
and by using a gradient elution for HPLC.  This method was successfully applied in a 
metabolic study for the determination of GroPIns uptake in C. albicans.  The application 
of the approach described in this Chapter has contributed to the publication in the 
Eukaryotic Cell journal (Bishop et al., 2011). 
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Chapter 3 
 
 
Simultaneous Quantification of Lipid-Related 
Extracellular Metabolites in Saccharomyces cerevisiae 
using HILIC-MS/MS: Application in Metabolomic Study1 
 
 
 
 
 
 
 
 
1
The work described in this Chapter is presented in the following manuscript: 
Sun, T.; Wetzel, S. J.; Johnson, M. E.; Surlow, B. A.; Patton-Vogt, J. Development and 
validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry 
method for the quantification of lipid-related extracellular metabolites in Saccharomyces 
cerevisiae, Journal of Chromatography B, 2012, Accepted pending revisions. 
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3.1 Abstract 
 
In this Chapter, a highly sensitive hydrophilic interaction liquid chromatography-
tandem mass spectrometry (HILIC-MS/MS) method was developed and validated for the 
quantification of glycerophosphoinositol (GroPIns), glycerophosphocholine (GroPCho), 
glycerol 3-phosphate (GroP), inositol, and choline in the extracellular medium of 
Saccharomyces cerevisiae.  The media samples were pretreated with a single two-phase 
liquid extraction.  Chromatographic separation was achieved on a Waters Xbridge HILIC 
(150×4.6 mm, 5 μm) column under isocratic conditions using a mobile phase composed 
of acetonitrile/water, 70:30 (v/v) with 10 mM ammonium acetate at a flow-rate of 0.5 
mL/min.  Using a triple quadrupole tandem mass spectrometer, samples were detected in 
multiple reaction monitoring (MRM) mode via an electrospray ionization (ESI) source.  
The calibration curves were linear (r
2≥0.995) over the range of 0.5-150 nM, with the 
lower limit of quantitation validated at 0.5 nM for all analytes.  The intra- and inter-day 
precision ranged from 1.24 to 5.88% and 2.46 to 9.77% (CV%), respectively, and intra- 
and inter-day accuracy was between -8.42 to 8.22% and -9.35 to 6.62% (RE%), 
respectively, at all quality control levels.  The extracellular metabolites were stable 
throughout various storage stability studies.  The fully validated method was successfully 
applied to determine the extracellular levels of phospholipid-related metabolites in S. 
cerevisiae. 
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3.2 Introduction 
 
The metabolome represents the full collection of low-molecular weight chemical 
species within a cell or biological system, and is considered the endpoint of “omics 
analysis” [1-3].  Current research on metabolomic investigation consists of four 
complementary approaches: target analysis, metabolic profiling, metabolic fingerprinting, 
and metabolic footprinting [4-6].  All of these approaches are usually applied to 
investigate differences in metabolite concentrations after alterations in the biological 
environment or upon genetic modification.  The measurement of extracellular metabolites 
secreted from the intracellular volume into the growth medium is termed “metabolic 
footprinting”.  Footprinting analysis offers important technical advantages over the 
analysis of intracellular compounds, referred to as “metabolic fingerprinting” [7-9].  First 
of all, the extracellualar metabolome is generally quite stable owing to the relative lack of 
enzymes that can convert the metabolites into other products.  Therefore, the time-
consuming quenching steps associated with the analysis of intracellular metabolites are 
not required when extracellular metabolites are analyzed.  In addition, the extracellular 
metabolome is generally simplified in terms of the number of metabolites present and 
their concentration ranges as compared to the intracellular metabolome, but can still 
provide important insight into cellular metabolism [7].  Metabolic footprinting has been 
used in the classification of microbial mutants for functional genomics studies by 
employing mass spectrometry (MS) [3, 10-12] or nuclear magnetic resonance (NMR) 
analysis [13].  For yeast and mammalian cells, metabolic footprinting has been performed 
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under a limited number of conditions, and has primarily focused on central carbon 
metabolites [14-18].  To our knowledge, no metabolic footprinting study has focused on 
lipid metabolites. 
The simple eukaryote, Saccharomyces cerevisiae, has been used as a model to 
study many aspects of cell biology, including lipid metabolism [19-23].  We have chosen 
to monitor five major phospholipid metabolites in the media of S. cerevisiae: inositol, 
choline, glycerol 3-phosphate, glycerophosphoinositol, and glycerophosphocholine 
(Table 3-1).  The lipid precursors inositol and choline regulate phospholipid biosynthesis 
at the transcriptional level in S. cerevisiae [24].  Thus, they are frequently added to and 
removed from medium to study and manipulate the biosynthetic pathways.  In addition, 
inositol and choline can be produced by the cell via lipid turnover events.  We chose to 
monitor GroP as it represents a metabolite that could be produced through phospholipid 
turnover, and is also a metabolic precursor involved in phospholipid biosynthesis.  
Finally, extracellular GroPIns and GroPCho are produced through the hydrolytic 
cleavage of both acylester bonds of plasma membrane-associated glycerophospholipids 
by phospholipase B type enzymes [20, 21, 25].  Thus, extracellular GroPIns and 
GroPCho can be monitored as an indicator of phospholipase B activity encoded by the 
PLB1, PLB2, and PLB3 genes.  Overall, the concentration of each of these metabolites in 
the medium is the result of two processes: their production via enzymatic activity and 
their uptake via plasma membrane transport.  
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Name Structure 
Glycerophosphoinostol 
 
Glycerophosphocholine 
 
Glycerol 3-phosphate 
 
Inositol 
 
Choline 
 
Choline-d9 
 
Table 3-1 Molecular structures of five lipid-related metabolites and internal standard. 
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This method was developed in order to create a simplified and sensitive method for 
the absolute and simultaneous quantitation of the levels of important phospholipid 
metabolites in the media of S. cerevisiae.  Previous studies in which one or more of the 
compounds has been monitored usually involve the use of radioactivity, as the 
compounds have no UV or fluorescence detectable groups.  For example, 
3
H or 
14
C 
labeled inositol or choline, and 
32
P-H3PO4 are typically utilized [26-28].  However, 
measuring all of these compounds simultaneously with multiple radioactive compounds 
is technically challenging, even if a good separation system is at hand.  In addition, the 
use of radioactive molecules can also present a quantitation problem.  For example, since 
S. cerevisiae can both synthesize and import inositol and choline, radioactive labeling 
only allows for the discrimination of inositol and choline transported into the cell, not 
that derived from de novo synthesis.  In contrast, MS detects all chemical species, 
regardless of their mode of synthesis.  Finally, the method described here is an advance in 
terms of the LC separation of the compounds.  While published procedure has described 
the chromatographic separation of choline-containing metabolites, and inositol-
containing metabolites, we know of no published procedure for the LC separation of all 
five of these compounds simultaneously [ 29-31].   
Two published studies are pertinent to the method described here.  A LC-MS/MS 
method using a β-cyclodextrin-bonded column was described for the quantitative analysis 
of internal GroPIns in rat cell lines, but other metabolites were not included in this 
method [32].  Another study used normal phase LC-MS to quantitate several water-
soluble metabolites, including GroPIns and GroPCho, from rat brain tissue 
33
.   Our 
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method differs from that of Kopp et al [33] in that we perform extensive method 
validation, we analyze an overlapping but different set of metabolites, and we use HILIC 
chromatography, which results in decreased retention times as compared to normal phase. 
Here, we present a hydrophilic interaction liquid chromatography-tandem mass 
spectrometry (HILIC-MS/MS) method for the quantification of five lipid-related 
extracellular metabolites in S. cerevisiae cells.  A liquid-liquid extraction procedure has 
been combined with an extensive optimization of HILIC-MS/MS methodology to provide 
effective and reliable chromatographic separation of analytes in the supernatant of 
extracellular medium.  The method is highly sensitive and has been thoroughly validated 
according to the bioanalytical method validation guidelines for industry as specified by 
the US Food and Drug Administration (FDA) (www.fda.gov/downloads /Drugs/Guidance 
ComplianceRegulatoryInformation/Guidances/ucm070107.pdf). 
 
 
3.3 Experimental 
3.3.1 Materials and Regents 
 
Standard compounds including glycerophosphoinositol (L-α–glycerophospho –D–
myo-inositol), glycerophosphocholine (L-α–glycerophosphorylcholine), glycerol 3-
phosphate (L-α–glycero-phosphate), myo-inositol, and choline chloride were purchased 
from Sigma-Aldrich (St. Louis, MO, USA).  The deuterated internal standard (IS), 
choline chloride-d9, was obtained from Cambridge Isotopes (Andover, MA, USA).  
Ammonium acetate was purchased from Fisher Scientific (Pittsburgh, PA, USA).  
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Optima grade methanol and acetonitrile used for LC-MS/MS analysis were also 
purchased from Fisher Scientific.  Deionized water was obtained using a Milli-Q water 
purification system from Millipore (Bedford, MA, USA). 
 
 
3.3.2 Preparation of Standard Solutions and Quality Control Samples 
 
Primary stock solutions of glycerophosphoinositol (GroPIns), glycerophospho- 
choline (GroPCho), glycerol 3-phosphate (GroP), myo-inositol, choline chloride, and 
choline chloride-d9 (IS) were prepared in methanol/water, 1:1 (v/v) at a concentration of 
50 mM, respectively.  Working standard solutions were made by diluting the primary 
stock solutions in water to a concentration of 10 μM.  A working standard solution of the 
internal standard (choline-d9) in 2.5 μM was prepared by diluting its primary stock 
solution in deionized water.  Eight calibration standards were prepared by adding 25 μL 
aliquots of appropriate dilution of the working standard solutions and internal standard to 
475 μL aliquots of the blank medium to obtain the following concentrations: 0.5, 1.5, 5, 
10, 30, 60, 90 and 150 nM.  Quality control (QC) samples were prepared at 
concentrations of 2 nM (low QC, LQC), 50 nM (middle QC, MQC), and 100 nM (high 
QC, HQC) by spiking the blank media with the working standard solutions.  The primary 
stock solutions, working standard solutions and QC samples were stored at -20°C until 
use. 
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3.3.3 Culture Conditions and Sample Preparation 
 
The S. cerevisiae wild type strains, BY4741 (JPV203, MATa his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0) and BY4742 (JPV399, MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) were 
purchased from Open Biosystems (Thermo Scientific, Huntsville, AL, USA).  The 
deletion strains were constructed using standard homologous recombination techniques.  
Drug resistant markers, hph, KanMX, and nat1 were amplified from plasmids pAG32, 
pUG6, and pAG25, respectively, and were inserted in place of the target genes for 
deletion.  The plasmids were received from Euroscarf [34, 35]. Deletion strains were 
constructed in JPV203 to produce plb1::hph (JPV617), plb2::KanMX (JPV618), 
plb3::nat1 (JPV 619), plb1::hph/plb2::KanMX/plb3::nat1 (JPV623), and in strain 
JPV399 to produce plb1::hph (JPV668).  Strains were grown aerobically at 30°C in yeast 
nitrogen base (YNB) medium containing 75 μM inositol, 20 μM choline, and 2 mM 
KH2PO4 instead of normal 7.35 mM KH2PO4 in order to minimize ion suppression in 
mass spectrometry.  Growth was monitored by measuring the OD 600 nm using a 
Biomate 3 Thermo Spectronic spectrophotometer.   
To prepare medium samples, culture aliquots were centrifuged at 3000 rpm for 5 
min, and the resulting supernatant was filtered.  A liquid-liquid extraction approach was 
performed in order to separate polar lipid metabolites from the non-polar materials in the 
extracelluar medium.  10 μL of internal standard working solution and 100 μL aliquots of 
the metabolite containing supernatant were added to 890 μL of chloroform/methanol, 2:1 
(v/v).  This mixture was vortexed for 2 min, followed by centrifugation at 3000 rpm for 3 
min.  A 200 μL aliquot of the upper phase (49.3 ± 1.0% of the total analytes) was 
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collected and transferred into a 1.5-mL HPLC vial for evaporation under nitrogen.  The 
residue was reconstituted in 200 μL of acetonitrile/methanol, 75:25 (v/v) and was diluted 
in 1:100 fold volumes before analysis.  The sample injection volume to LC-MS/MS 
system was 10 μL. 
 
 
3.3.4 Instrumentation 
 
Chromatographic studies were performed via a 1200 series Rapid Resolution LC 
system coupled with a 6440 Triple Quadrupole Mass Spectrometer (Agilent, Santa Clara, 
CA, USA).  MassHunter workstation software package was used for data acquisition and 
processing.  Quantification was determined using Qualitative (B1.0.82.2) and 
Quantitative (B1.0.77.3) Analysis as implemented in the MassHunter software. 
 
 
3.3.4.1 Chromatographic Conditions 
 
The analytical column used was a Waters Xbridge HILIC (150×4.6 mm, 5 μm) 
column from Waters Corporation (Milford, MA, USA).  Separations were performed 
under isocratic conditions at a flow rate of 0.5 mL/min at room temperature.  Mobile 
phase consisted of acetonitrile/water, 70:30 (v/v) with 10 mM ammonium acetate at pH 
4.5.  Column effluent was then passed through the mass spectrometer for later detection. 
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3.3.4.2 MS Settings 
 
Electrospray mass spectrometry (ESI-MS) was performed on a triple quadrupole 
mass spectrometer.  Mass transitions of m/z for each metabolite and IS were optimized 
by direct infusion of the respective analytes in acetonitrile/water, 70:30 (v/v) with 10 mM 
ammonium acetate in product ion mode.  Optimum settings for subsequent LC-MS 
analyses were manually adjusted.  Metabolites were detected in both positive and 
negative ionization modes at different time segments in one run using multiple reaction 
monitoring (MRM).  Other MS parameters were set as follows: capillary voltage of 3.5 
KV, drying gas temperature of 300°C, fragmentor voltage of 50 V, and sheath gas 
temperature of 325°C.  Sheath gas flow and drying gas flow rates (both are nitrogen) 
were set at 10 and 8 L/min, respectively.  Low and high mass resolutions were fixed at 15 
(arbitrary units) for both the first and third quadrupole mass analyzers.  Dwell time and 
interchannel delay were maintained at 200 and 10 ms, respectively.  Collision energy in 
the rf-only quadrupole cell and transitions were optimized for each metabolite on the 
reference compound.  The starting parameters of ESI source for small molecules from the 
manufacture’s instruction are illustrated in Table 3-2. 
 
Flow dependent parameters Compound dependent parameters 
Nebulizer pressure 30 psi Capillary voltage 2 kV 
Drying gas flow 5 L/min Fragmentor voltage 10 V 
Drying gas temperature 200 °C Collision energy 0 eV 
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Sheath gas flow 8 L/min Sheath gas temperature 250 °C 
Table 3-2 Starting parameters for ESI source optimization. 
 
 
3.3.5 Method Validation 
 
The LC-MS/MS method was validated through evaluation of specificity, linearity, 
sensitivity, intra- and inter-day precision, accuracy, recovery, and stability in accordance 
with currently approved FDA bioanalytical method validation guidelines. 
 
 
3.3.5.1 Specificity and Selectivity 
 
To determine if endogenous contaminants were present in coelution with the 
analytes, the chromatography was developed and the MS/MS parameters were optimized 
to obtain separation of the analytes from potentially interfering compounds as well as the 
highest signal to noise ratios. 
 
 
3.3.5.2 Linearity of Calibration Standards, Precision, and Accuracy 
 
Linearity was evaluated over the concentration range of 0.5 to 150 nM.  The 
calibration curve was constructed by plotting the peak area ratio of analyte to that of IS 
against the nominal concentration of calibration standards.  The results were fitted to 
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least-squares linear regression analysis with a correlation coefficient of 0.995 or better.  
Intra-day and inter-day precision and accuracy were determined through analysis of six 
replicates at four different levels (0.5, 2, 50 and 100 nM) during the same day and on 
three different days.  The precision was determined by calculating the coefficient of 
variation (CV), and the accuracy was expressed in the form of the relative error (RE), 
which was calculated as the percent deviation of the mean from the true value.  The 
acceptance criteria of the data included precision within ±15% CV from the nominal 
values and an accuracy of within ±15% RE, except for LLOQ, where it should not exceed 
±20% of accuracy as well as precision (Bioanalytical method validation guidelines of 
FDA). 
 
 
3.3.5.3 Recovery 
 
The extraction recoveries of analytes from medium were determined by comparing 
the mean peak areas of medium spiked with standards at three levels (2, 50 and 100 nM, 
n=6) to those of blank medium extracts spiked with standards at equivalent 
concentrations, corrected for the evaporated volume of organic phase.  The recovery of 
the internal standard was determined at a concentration of 50 nM. 
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3.3.5.4 Matrix Effect 
 
Matrix effects from the medium samples were evaluated by comparing the peak 
areas of the spiked blank medium extracts (2, 50 and 100 nM, n=6) to the peak areas 
from standards spiked in mobile phase of acetonitrile/water, 70:30 (v/v) with 10 mM 
ammonium acetate. 
 
 
3.3.5.5 Stability 
 
The stability of analytes in medium was investigated using QC samples (2 and 100 
nM) stored under different temperature conditions for different periods of time.  The six 
replicates were subjected to three freeze (12, 18 and 24 h) – thaw (2, 3 and 4 h) cycles.  
Short-term storage stability was evaluated at room temperature for 4 h, and long-term 
storage stability at -20°C for 30 days.  Reinjections of QC samples (n=6) were analyzed 
after 24 h storage at the same concentrations in the autosampler. 
 
 
3.4 Results and Discussion 
3.4.1 Optimization of MS/MS Conditions 
 
The Agilent triple quadruple mass spectrometer applies Jet stream technology, of 
which the super-heated sheath gas collimates the nebulizer spray and presents more ions 
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to the MS inlet.  The source optimization for ESI-MS system is composed of two main 
parameters: flow dependent parameters and compound dependent parameters.  The flow 
dependent parameters include nebulizer pressure, drying gas temperature and flow and 
sheath gas flow, while the compound dependent parameters consist of capillary voltage, 
fragmentor voltage, collision energy and sheath gas temperature.  All the parameters had 
a substantial effect on the MS/MS determination of the analytes and thus their adjustment 
was crucial.  The optimum conditions for the determination of the metabolites by triple 
quadruple MS/MS extracted from this experiment are summarized in Table 3-3. 
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The standards of the analytes were first characterized by total ion scan and product 
ion scan through direct infusion to ascertain their precursor ions and to select product 
ions for use in MRM mode.  Voltages and gas flow changed quickly and were optimized 
with series of flow injections.  Temperatures including sheath gas and drying gas needed 
equilibration time between injections.  The MS/MS parameters, specifically fragmentor 
voltage and collision energy, were evaluated for the best response of the parent ion and 
daughter ion, respectively, using the starting parameters above for ESI source and then 
transferred to the MRM method.  Long dwell times were required for obtaining better 
sensitivity.  GroPCho, GroP, and choline were found to give the most intense protonated 
molecular ions under positive ionization, while GroPIns and inositol were detected in 
negative ionization mode.  The m/z values of precursor ions and fragment ions for each 
analyte are illustrated in Table 3-4. 
 
Analyte 
Ionization 
mode (m/z) 
Precursor 
ion (m/z) 
Transition 
pairs (m/z) 
Main fragmentation 
structure 
Choline Positive 104.1 104.1→60.1 
 
Choline-d9 Positive 113.1 113.1→69.1 
 
GroP Positive 172.7 172.7→98.8 
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Inositol Negative 178.7 178.7→86.8 
 
GroPCho Positive 258.0 258.0→104.0 
 
GroPIns Negative 333.0 333.0→152.9 
 
Table 3-4 Precursor ions, transition pairs and the corresponding main fragmentation structures 
for the analytes and internal standard. 
 
Full scan spectra produced a predominant peak for [M+H]
+
 at m/z 258.0 of 
GroPCho, 172.7 of GroP, 104.1 of choline, and 113.1 of internal standard, respectively.  
The deprotonated molecular ions [M-H]
-
 of GroPIns and inositol were detected at m/z 
333.0 and 178.7, respectively.  Collision induced dissociation of the precursor ions 
produced major fragmentation for each analyte.  Therefore, the transition pairs 
258.0→104.0 (Figure 3-1), 172.7→98.8 (Figure 3-2), 104.1→60.1 (Figure 3-3), and 
113.1→69.1 (Figure 3-4) were optimized for GroPCho, GroP, choline, and choline-d9, 
respectively.  Using similar procedures, the MRM transition of GroPIns and inositol were 
determined to be 333.0→152.9 (Figure 3-5), and 178.7→86.8 (Figure 3-6), respectively.  
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 Figure 3-1 Tandem mass spectra of the GroPCho by product ion scan in positive mode. 
 
 Figure 3-2 Tandem mass spectra of the GroP by product ion scan in positive mode. 
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Figure 3-3 Tandem mass spectra of the choline by product ion scan in positive mode. 
 
 
Figure 3-4 Tandem mass spectra of the choline-d9 by product ion scan in positive mode. 
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Figure 3-5 Tandem mass spectra of the GroPIns by product ion scan in negative mode. 
 
 
Figure 3-6 Tandem mass spectra of the inositol by product ion scan in negative mode. 
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3.4.2 Optimization of LC Conditions 
 
Polar lipid-related metabolites were extracted from the extracellular medium by a 
liquid-liquid extraction.  Chloroform/methanol, 2:1 (v/v) was used as the extraction 
solvent to remove non-polar compounds from the medium.  The choice of a 
chromatography method was less straightforward since a diverse range of metabolites at 
widely differing concentrations are present in culture medium.  A HILIC column was 
chosen as an appropriate approach based on a review of the literatures for smaller 
hydrophilic and ionizable analytes [36-45].  A Waters Xbridge HILIC (150×4.6 mm, 5 
μm) column was selected to provide the best compromise between specificity and speed 
of analysis.  With the optimum isocratic elution, the metabolites were adequately 
separated with retention times of 5.58 min for inositol, 15.47 min for GroP, 15.68 min for 
GroPIns, 5.39 min for GroPCho, and coelution of choline and choline-d9 at 3.38 and 3.37 
min, respectively (Figure 3-7B).   
 
 
3.4.3 Method Validation 
3.4.3.1 Specificity and Selectivity 
 
Representative chromatograms of blank medium, a spiked medium sample, and the 
medium obtained after growth of a wild type strain were shown in Figure 3-7.  No 
interference with the retention time of the analytes and internal standard (Figure 3-7B and 
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3-7C) was observed in the blank medium (Figure 3-7A), indicating the specificity of the 
present method. 
 
 
Figure 3-7 Representative LC-MS/MS chromatograms of (A) a blank medium (noise baseline), (B) 
medium sample spiked with analytes and internal standard at 0.5 nM (LLOQ), and (C) medium 
from a wild type strain (JPV203) spiked with internal standard at 0.5 nM. 
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3.4.3.2 Linearity of Calibration and LLOQ 
 
The calibration curves were constructed by plotting the instrument response (peak 
area ratio (analyte/IS)) versus calibration standard concentration.  A linear relationship 
was constructed over the concentration range of 0.5-150 nM.  Correlation coefficients (r
2
) 
of the calibration curves for all standards ranged between 0.995 and 0.997 (Figure 3-8, 3-
9, 3-10, 3-11 and 3-12).  The precisions (CV%) were less than 8.7%, and the accuracies 
(RE%) were within the range of -6.2 to 8.3% in Table 3-5.  Using the present method, the 
LLOQ was validated at 0.5 nM for all analytes, which is equivalent to 186, 129, 185, 90 
and 70 pg/mL for GroPIns, GroPCho, GroP, inositol, and choline, respectively.  Under 
the present LLOQ, the concentration of analyte in the medium can be determined even 24 
h after administration.  As a result, this method was sensitive enough to investigate the 
levels of these metabolites in the exometabolome of S. cerevisiae. 
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Figure 3-8 Plot of the peak area ratio of GroPIns to internal standard versus the concentration of 
GroPIns. 
 
Figure 3-9 Plot of the peak area ratio of GroPCho to internal standard versus the concentration of 
GroPCho. 
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Figure 3-10 Plot of the peak area ratio of GroP to internal standard versus the concentration of 
GroP. 
 
Figure 3-11 Plot of the peak area ratio of inositol to internal standard versus the concentration of 
inositol. 
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Figure 3-12 Plot of the peak area ratio of choline to internal standard versus the concentration of 
choline. 
 
 
3.4.3.3 Recovery 
 
The mean extraction recoveries of analytes in Table 3-7 were 74.4% for GroPIns, 
72.6% for GroPCho, 80.7% for GroP, 82.5% for inositol, 75.9% for choline, and 75.5% 
for IS at 50 nM.  The simple sample extraction procedure with 10 volumes of 
chloroform/methanol, 2:1 (v/v) to 1 volume of sample allowed for high sample 
throughputs and good recoveries.  No significant degradation occurred under any 
experimental condition. 
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Analyte Nominal concentration (nM) 
 0.5 1.5 5 10 30 60 90 150 
GroPIns         
Mean 0.47 1.52 5.06 9.73 31.84 63.92 94.21 146.62 
Precision (CV%)
b 
3.44 2.79 6.82 5.40 4.27 6.98 3.18 4.02 
Accuracy (RE%)
c 
-6.24 1.33 1.24 -2.75 6.13 6.53 4.68 -2.25 
GroPCho         
Mean 0.50 1.47 4.93 10.44 30.37 62.82 92.29 145.22 
Precision (CV%) 4.29 8.70 3.37 6.13 4.28 3.27 4.91 2.47 
Accuracy (RE%) 0.03 -2.73 -1.42 4.42 1.23 4.75 2.54 -3.19 
GroP         
Mean 0.52 1.46 5.09 9.52 29.64 57.28 88.74 146.25 
Precision (CV%) 4.25 1.57 3.81 2.39 5.07 2.73 4.20 3.31 
Accuracy (RE%) 4.20 2.67 1.83 -4.88 1.21 -4.53 -1.45 -2.58 
Inositol         
Mean 0.46 1.58 5.12 10.67 30.88 58.73 93.64 147.27 
Precision (CV%) 2.55 4.98 6.96 3.38 5.26 3.01 2.29 4.47 
Accuracy (RE%) 8.31 5.33 2.46 6.70 2.93 -2.12 4.04 -1.82 
Choline         
Mean 0.51 1.54 4.85 9.82 29.64 62.49 85.26 145.72 
Precision (CV%) 3.01 6.28 4.11 5.26 4.42 1.57 2.06 6.31 
Accuracy (RE%) 2.11 2.67 -3.31 -1.87 -1.22 4.15 -5.27 -2.85 
Table 3-5 Precision and accuracy of calibration samples (n=6 in 3 runs).  The coefficient of 
variation (CV%) = [Standard deviation/mean concentration measured] × 100.  The relative error 
(RE%) = [(mean concentration measured-nominal concentration)/nominal concentration] × 100. 
 
3.4.3.4 Precision and Accuracy 
 
Table 3-6 is a summary of the intra - and inter-day precision and accuracy 
validation using QC samples as described in Section 3.3.5.2.  QC samples were 
determined in replicate (n = 6) at three different concentrations: 2, 50, and 100 nM.  
Within the range of 2–100 nM, the intra-day and inter-day precisions (CV%) were 
between 1.2 to 9.8% for each QC level of analytes.  The accuracy (RE%), determined for 
QC samples, was within -9.3 to 8.3% for each QC level of analytes. 
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Analyte Intra-day (n=6)  Inter-day (n=6) 
(nM) Mean SD 
PRE 
(CV%) 
ACC 
(RE%) 
 Mean
 
SD 
PRE 
(CV%) 
ACC 
(RE%) 
GroPIns          
2 2.04 0.12 5.88 2.16  1.92 0.09 4.69 -4.64 
50 48.37 1.46 3.02. -3.26  53.25 3.64 6.84 6.52 
100 92.66 2.27 2.45 -7.34  90.66 5.82 6.42 -9.35 
GroPCh
o 
         
2 1.97 0.09 4.57 -1.58  2.05 0.11 5.37 2.51 
50 52.01 2.42 4.65 4.02  47.62 1.17 2.46 -4.76 
100 94.67 1.17 1.24 -5.33  92.13 3.87 4.20 -7.87 
GroP          
2 1.89 0.07 3.70 -5.53  1.94 0.14 7.22 -3.68 
50 51.39 1.98 3.85 2.78  53.22 4.21 7.91 6.44 
100 96.64 4.61 4.77 -3.36  95.27 2.36 2.48 -4.73 
Inositol          
2 2.07 0.11 5.31 3.54  1.97 0.14 7.11 -3.74 
50 47.65 2.61 5.48 -4.77  47.29 4.62 9.77 -5.42 
100 91.58 3.52 3.84 -8.42  94.63 3.10 3.28 -5.37 
Choline          
2 1.92 0.06 3.13 -4.65  1.95 0.09 4.62 -2.52 
50 54.11 1.29 2.38 8.22-  46.74 2.73 5.84 -6.53 
100 94.28 4.17 4.42 -5.72  92.18 4.71 5.11 -7.82 
Table 3-6 Intra- and inter-day precision and accuracy of the QC samples (n=6 in 3 runs).  SD: 
standard deviation.  PRE: precision.  ACC: accuracy.  The coefficient of variation (CV%) = 
[Standard deviation/mean concentration measured] × 100.  The relative error (RE%) = [(mean 
concentration measured-nominal concentration)/nominal concentration] × 100. 
 
 
3.4.3.5 Matrix Effect 
 
The absolute matrix effects, the ratio of the peak areas of three-concentration level 
standards spiked in medium extracts to areas of the standards spiked in mobile phase (10 
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mM ammonium acetate in acetonitrile/water, 70:30 (v/v)), were measured to be 95.6%, 
97.7%, 98.4%, 95.3%, and 97.0% for GroPIns, GroPCho, GroP, inositol, and choline, 
respectively (Table 3-7).  The matrix effect value of <100% indicates ionization 
suppression.  The matrix was found to have negligible impact on the ionization, as the 
variation in signal was less than 10% for all analytes.  The absolute matrix effect value of 
IS at 50 nM in the medium was observed to be 96.7%. 
 
Analyte Absolute matrix effect (%)  Recovery (%) 
 LQC MQC HQC Mean  LQC MQC HQC Mean 
GroPIns 97.2 94.3 95.3 95.6  72.5 75.1 75.6 74.4 
GroPCho 97.4 95.9 99.8 97.7  70.5 72.9 74.4 72.6 
GroP 98.5 97.6 99.0 98.4  81.7 78.4 82.0 80.7 
Inositol 94.2 96.6 95.1 95.3  82.9 83.3 81.3 82.5 
Choline 98.6 95.1 97.3 97.0  73.6 77.9 76.2 75.9 
Figure 3-7 Absolute matrix effect and recovery of all analytes at three concentrations of 2, 50 and 
100 nM (n=6 in 3 runs).  Absolute matrix effect expressed as the ratio of the mean peak areas of 
three-concentration level standards spiked in medium extracts to those from standards spiked in 
the mobile phase multiplied by 100.  Recovery calculated as the ratio of the mean peak areas of 
medium spiked with standards at three levels to those of blank medium extracts spiked with 
standards at equivalent concentrations multiplied by 100. 
 
 
3.4.3.6 Stability 
 
The stability of QC samples at 2 and 100 nM were determined after the following 
manipulations: three freeze/thaw cycles, 4-h storage at room temperature, 30-day storage 
at -20°C, and autosampler reinjection after 24 h (Table 3-8).  QC samples were stable in 
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different storage conditions, as their assay values were within the acceptable limits of 
accuracy (±15% RE) and precision (±15% CV). 
 
Analyte  LQC  HQC 
 
Storage 
Conditio
n 
Mean 
(nM) 
PRE
 
(CV%) 
ACC
 
(RE%) 
 
Mean 
(nM) 
PRE 
(CV%) 
ACC 
(RE%) 
GroPIns FT-3 1.97 2.72 -1.54  96.28 4.67 -3.85 
 Short-T 1.99 4.63 -0.58  97.52 5.05 -2.54 
 Long-T 2.02 3.57 -1.45  95.05 3.52 -5.62 
 Auto-R 1.85 4.48 -7.56  89.94 4.34 -10.11 
GroPCho FT-3 1.96 5.12 -2.81  97.77 2.78 -2.36 
 Short-T 1.98 4.80 -1.70  99.56 3.41 -0.58 
 Long-T 1.94 4.27 -3.35  93.23 2.90 -6.84 
 Auto-R 1.88 3.92 -6.12  91.02 5.33 -9.42 
GroP FT-3 1.97 3.16 -0.15  100.43 4.01 0.49 
 Short-T 2.01 2.57 0.54  97.22 4.26 -2.84 
 Long-T 1.90 4.43 -5.03  96.39 5.53 -3.76 
 Auto-R 1.89 3.87 -5.56  88.54 3.11 -11.52 
Inositol FT-3 1.96 2.64 -2.68  94.60 2.46 -5.44 
 Short-T 2.02 4.39 1.32  97.91 5.18 -2.16 
 Long-T 1.98 3.61 -1.60  95.13 3.62 -4.92 
 Auto-R 1.84 4.74 -7.25  90.67 4.54 -9.47 
Choline FT-3 2.03 5.89 1.59  97.92 4.36 -2.18 
 Short-T 1.95 3.72 -2.52  99.36 2.91 -0.72 
 Long-T 1.91 3.24 -4.52  89.63 3.83 -10.45 
 Auto-R 1.87 2.67 -6.58  90.42 4.06 -9.64 
Table 3-8 Stability of QC samples (n=6).  FT-3: three freeze/thaw cycles.  Short-T: 4-h storage at 
room temperature.  Long-T: 30-day storage at -20°C.  Auto-R: autosampler reinjection after 24 h 
at room temperature.  The coefficient of variation (CV%) = [Standard deviation/mean 
concentration measured] × 100.  The relative error (RE%) = [(mean concentration measured-
nominal concentration)/nominal concentration] × 100. 
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3.4.4 Application to a Biological Analysis 
 
To apply the developed method to a biological system, we monitored the medium 
of S. cerevisiae cultures containing wild type cells and cultures containing mutant strains 
in which one or more of the phospholipase B genes had been deleted.  We first monitored 
the culture medium prior to the addition of cells in order to get a zero time reading 
(Figure 3-13) and again after several hours, at which point the cells had reached the 
stationary phase of growth (Figure 3-14). 
Based on prior literature using radiolabeling, we expected to see a decrease in 
GroPCho levels in strains lacking the PLB1 gene and a decrease in GroPIns levels in 
strains lacking the PLB3 gene, but had no firm estimate of the absolute quantities of these 
metabolites [20, 21, 46].  Since we supplemented the medium with inositol and choline, 
we expected to see a decrease in those metabolites as a function of growth, but did dot 
have an estimate of the extent of uptake by the cells.  With regard to GroP, we did not 
know if this compound would be detected extracellularly and had no expectation 
regarding its extracellular concentration.  As shown in Figure 3-13, the mean 
concentrations of inositol and choline in blank medium were determined to be 61.8 μM 
and 15.18 μM, which are in close agreement with the supplemented concentrations of 
75μ M and 20 μM when the recovery values of 82.5% and 75.9% are taken into 
consideration. 
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Figure 3-13 Blank medium supplemented with 75 μM inositol, and 20 μM choline was analyzed 
at time 0.  Data represented as concentration (μM) as a function of cell growth (OD600).  The error 
bars represent the variation of three individual experiments. Values represent mean ± S.E. of 
triplicate determinations. 
 
As shown in Figure 3-14, the concentration of inositol decreased in all strains to 
approximately 22-25 μM.  Interestingly, the concentration of choline in the medium 
decreased to a greater extent for the wild type strain than it did for any of the strains 
bearing a mutated copy of a PLB gene.  This finding suggests that either choline transport 
is diminished in the mutant strains or that the production and subsequent release of 
choline is exacerbated in the mutant strains.  Further studies will be needed in order to 
reconcile these possibilities.   
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Figure 3-14 Determination of lipid-related extracellular metabolites of S. cerevisiae in wild cells 
and in response to deletion of PLB1, PLB2, and PLB3 genes encoding for phospholipases B. 
Strains grown in medium were harvested at stationary phase after approximately 24 hours of 
growth for the PLB activity assays.  Data represented as concentration (μM) as a function of cell 
growth (OD600).  The inset showed the mean concentrations of GroPIns and GroPCho in detail.  
The error bars represent the variation of three individual experiments.  Values represent mean ± 
S.E. of triplicate determinations. 
 
Also interesting is that not only is GroP detected in the medium, but that the level 
is greater in the wild type strain than in any of the mutant strains.  Again, further 
experiments will be needed to understand the metabolic underpinnings of this result.  
With regard to GroPCho levels, we observed the most severe decrease in levels in the 
plb1Δ and plb1-3Δ mutant as compared to the wild type strain, as expected.  Somewhat 
surprising was that the plb2Δ and plb3Δ mutants also exhibited a decrease in GroPCho, 
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whereas the published data using radiolabeling saw little or no decrease in that metabolite 
in the plb2Δ and plb3Δ strains [20, 21, 46].  These differences may be due to the 
limitations associated with radiolabeling with 
14
C-choline, since only the pool of choline 
taken up by the cell is labeled and not that derived from de novo synthesis.  Also, genetic 
differences between the strain backgrounds and variations in the time of growth between 
the experiments may account for these differences.  With regard to GroPIns levels, we 
did not see a decrease in the plb3Δ mutant strain, contrary to what we expected from the 
literature [20, 21, 46].  Therefore, we performed another experiment using only a wild 
type strain and a plb3Δ mutant (Figure 3-15) in which we monitored the level of 
metabolites at an earlier point in their growth phase, the logarithmic phase of growth, as 
careful examination of the published reports suggest that those studies were likely 
performed with logarithmically growing cells.  Under those conditions, we observed the 
expected approximately 50% decrease in GroPIns levels in the plb3Δ mutant as 
compared to wild type (Figure 3-15). 
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Figure 3-15 Determination of lipid-related extracellular metabolites of S. cerevisiae in wild cells 
and in response to deletion of PLB3 genes encoding for phospholipases B.  Strains grown in 
medium were harvested at log phase after 10-12 hours of growth for the PLB activity assays.  
Data represented as concentration (μM) as a function of cell growth (OD600).  The inset showed 
the mean concentrations of GroPIns and GroPCho in detail.  The error bars represent the 
variation of three individual experiments.  Values represent mean ± S.E. of triplicate 
determinations. 
 
To summarize the biological application of this newly developed methodology, we 
were able to confirm the general trends expected for the extracellular levels of GroPIns 
and GroPCho in wild type and mutant strains.  However, much additional information 
was obtained regarding the absolute levels of these metabolites and the levels of GroP, 
inositol, and choline in the medium as a function of growth and the absence of particular 
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PLB encoding genes.  Thus, the application of this approach has opened up new avenues 
of potential research.  
 
 
3.5 Conclusions 
 
We have successfully developed and validated an efficient analytical method based 
on HILIC-MS/MS for the quantification of lipid-related extracellular metabolites in S. 
cerevisiae.  In comparison with traditional radiolabelling methods and other LC-MS/MS 
methods, our approach is simple, robust, and well suited to metabolomic studies.   
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Appendix 1 
 
 
Comparison of On-chip Lipid Extraction Method Using 
Different Eluents on Silica or C18 Stationary Phases to 
Bligh and Dyer Extraction Method for Evaluating the 
Extraction Efficiency of Microchip 
 
A.1 Abstract 
 
A library for comparing the identified phospholipids extracted from microchip using 
different eluents: methanol, isopropanol or acetonitrile on silica stationary phase and 2:1 
chloroform/methanol or 1:1 tetrahydrofuran/methanol on C18 stationary phase with the 
total lipid species extracted by Bligh and Dyer method.  From the results, the on-chip 
extraction efficiency is achieved as the number of identified phospholipids species 
obtained using the microchip method as compared to the modified Bligh-Dyer method. 
 127 
m/z  
Bligh and Dyer 
Extraction 
Silica Phase C18 Phase 
MeOH IPA ACN 
2:1 
Chloroform
/MeOH 
1:1 
Tetrahydrofuran 
/MeOH 
985.7 
40:2 PIp/40:1 
PIp 
  x   x   
983.7 
40:2 PIp/40:3 
PIp 
  x   x   
979.6 
40:3 PIPp/40:4 
PIPe 
x   x     
973.6 38:0 PIP/44:2 PI x x x     
969.6 38:2 PIP/44:4 PI x   x   x 
963.5 38:5 PIP x   x     
959.6 
38:1 PIp/38:0 
PIp 
  x x     
957.6 
38:0 PIPp/38:1 
PIPe 
x x x     
955.6 
38:1 PIPp/38:2 
PIPe 
x x x     
953.6 
38:2 PIPp/38:3 
PIPe 
x x   x   
945.6 42:2 PI x   x     
935.7 42:0 PI/42:1 PI     x     
931.6 
36:0 Pip/36:1 
PIp 
  x x   x 
929.6 42:2 PIp x   x     
923.8 
42:5 Pip/42:6 
PIe 
x         
921.5 42:6 PIp x   x   x 
905.7 40:1PI/40:2 PI   x     x 
901.5 
40:2 PIp/40:3 
PIe 
x x x     
899.5 
40:3 Pip/40:4 
PIe 
x   x     
898.6 
44:2 PC/44:3 
PS/44:2 PS 
x   x x   
898.5 40:5 PI/40:6 PI x x x x x 
894.7 
44:4 PC/44:5 
PS/44:3 PC 
x   x x   
892.6 
44:6 PS/44:5 
PC/44:5 PS 
x x x     
890.6 44:6 PC/44:6 PS x x x     
882.6 
43:4 PS/44:10 
PC 
    x     
 128 
m/z  
Bligh and Dyer 
Extraction 
Silica Phase C18 Phase 
MeOH IPA ACN 
2:1 
Chloroform
/MeOH 
1:1 
Tetrahydrofuran 
/MeOH 
881.5 38:6 PI x   x x x 
880.7 43:4 PC x x x   x 
879.7 38:1 PI/38:0 PI   x x x x 
877.6 
38:0 Pip/38:1 
PIe 
x x x     
875.5 
32:0 PIp/32:1 
PIp 
    x     
869.5 38:5 PI/38:6 PI     x     
868.6 
42:3 PC/42:4 
PS/42:3 PS 
x x x x x 
866.7 
42:4 PC/42:5 
PS/42:4 PS 
x   x x   
865.6 37:0 PI/37:1 PI     x     
864.5 
42:5 PC/42:6 
PS/42:5 PS 
x   x     
861.7 36:2 PI/42:0 PG x     x   
860.6 
42:7 PC/41:0 
PC/44:0 PE 
  x x x   
859.6 42:2 PG/36:4 PI   x   x   
858.7 
42:0 PCp/42:1 
PCe/44:1 PE 
x x x x x 
857.5 36:4 PI/42:2 PG x x   x x 
856.6 
42:2 PSp 44:2 
PE 
x x x   x 
854.6 
42:10 PC/41:4 
PS 
  x     x 
851.6 36:0 PI/36:1 PI           
850.7 
44:5 PE/42:4 
PCp /42:5 PCe 
x     x   
850.6 
44:4 PE/42:5 
PSe 
x         
848.6 
42:6 Pce/40:0 PS 
/44:6 PE 
x x x x x 
847.6 
42:0 Pge/36:1 
PIp /36:2 PIe 
x x     x 
846.7 
40:0 PC/40:1 PS 
/42:6 PCp 
x x     x 
846.6 
42:6 PSp/40:0 
PS /44:6 PE 
x x   x x 
838.6 40:5 PS/40:4 PC       x x 
 129 
m/z  
Bligh and Dyer 
Extraction 
Silica Phase C18 Phase 
MeOH IPA ACN 
2:1 
Chloroform
/MeOH 
1:1 
Tetrahydrofuran 
/MeOH 
837.6 35:0 PI/35:1 PI   x   x x 
836.6 
40:5 PC/40:6 
PS/40:5 PS 
x x   x x 
835.6 34:1 PI x x x x   
832.6 
39:1 PS/39:0 
PC/42:0 PE 
      x   
831.5 34:3 PI/40:1 PG x         
830.7 
40:0 PCp/40:1 
Pce/40:1 PSp 
x x     x 
829.5 34:5 PI         x 
828.6 40:2 PS/40:3 PS       x x 
826.6 
40:3 PS/40:4 
PS/39:4 PS 
          
825.5 33:0 PI       x   
824.6 
39:4 PC/42:4 
PE/40:4 PS 
          
823.6 34:0 PI/34:1 PI   x   x x 
822.5 
40:4 PCp/40:5 
Pce/40:5 PSp 
x x   x   
821.6 39:0 PG/34:1 PI       x x 
820.6 
38:0 PS/40:5 
PCp /40:6 PS 
x x x     
819.5 40:8 PG   x     x 
818.6 
38:0 PC/38:1 PS 
/40:6 PCp 
x x     x 
816.6 
38:1 PC/38:2 PS 
/42:0 PE/38:1 PS 
/42:0 PEe 
x x x x x 
812.6 
38:3 PC/38:4 PS 
/42:2 Pep/38:3 
PS /42:2 PEe 
x     x   
810.5 
38:4 PC/38:5 PS 
/42:4 Pee/38:4 
PS/ 42:2 PEp 
x x     x 
806.6 
38:0 PSe/38:6 
PC, 42:5 PEp 
/42:6 PEe 
x x   x x 
805.6 38:0 PG x x   x x 
802.7 
38:0 PCp, 38:1 
PCp/38:1 x x x   x 
PSp/40:1 PE 
 130 
m/z  
Bligh and Dyer 
Extraction 
Silica Phase C18 Phase 
MeOH IPA ACN 
2:1 
Chloroform
/MeOH 
1:1 
Tetrahydrofuran 
/MeOH 
801.5 32:5 PI   x   x   
800.7 
38:1 PCp/38:2 
PCe/38:2 
PSp/40:2 PE 
x x x   x 
799.6 43:2 PA   x       
798.5 
38:2 PCp/38:3 
PCe/38:3 
PSp/40:3 PE 
x x     x 
797.5 31:0 PI   x       
796.5 
38:3 PCp/38:4 
PCe/38:4 
PSp/40:4 PE 
x x     x 
795.5 32:0 Pie/38:5 PG x     x x 
794.6 38:4 PC/38:5 PS       x   
793.6 38:0 PG/32:1 PI       x x 
792.6 38:5 PC/38:6 PC         x 
790.7 
36:0 PC/36:1 PS 
/40:0 PEe 
x x x   x 
790.6 37:0 PS x x   x x 
786.5 
36:2 PC/36:3 PS, 
40:1 Pep/40:2 
PEe 
  x x x x 
784.6 
36:3 PC/36:4 PS, 
40:2 Pep/40:3 
PEe 
x x   x x 
784.5 
36:3 PS/40:1 
PEp /40:2 PEe 
x x x x x 
782.6 
36:4 PC/40:4 
PEe 
x x x   x 
777.6 36:1 PG x x     x 
776.6 
36:0 PCe/38:0 
PE /40:6 PEp 
      x x 
774.5 35:2 PS/36:2 PS       x x 
772.5 35:3 PS x x   x x 
771.4 30:5 PI/36:3 PG x x x x x 
769.6 41:3 PA/29:0 PI   x   x x 
768.6 
38:4 PE/36:3 
PCp /36:4 
PCe/38:3 PE 
x     x x 
767.5 30:0 PIe x     x   
 131 
m/z  
Bligh and Dyer 
Extraction 
Silica Phase C18 Phase 
MeOH IPA ACN 
2:1 
Chloroform
/MeOH 
1:1 
Tetrahydrofuran 
/MeOH 
766.6 
36:4 PCp/38:5 
PE/38:4 PE 
x     x   
765.5 
30:0 Pip/30:1 
PIe 
x x x x   
764.6 34:0 PS/35:0 PS           
761.6 36:1 PG/36:2 PG   x   x x 
760.6 
34:1 PC/38:0 
PEp /38:1 
Pee/38:0 PEe 
x x   x x 
758.6 
34:2 PC/38:0 
PEp /38:1 PEe 
x x x   x 
757.5 
36:2 PGp/36:3 
PGe 
x         
754.5 
34:4 PC/38:3 
PEp /38:4 
Pee/38:2 
Pep/38:3 PEe 
x         
753.5 
28:0 PI/36:4 
PGp /36:5 PGe 
x     x x 
752.6 
38:3 Pep/38:4 
Pe/34:5 PC/38:4 
Pep/38:5 PEe 
x     x x 
751.6 35:0 PG/40:5 PA   x   x x 
751.3 22:0 PIp   x   x x 
750.6 33:0 PS/34:0 PS x     x x 
749.4 28:2 PI/34:0 PG x     x x 
746.6 
34:0 PC/34:1 
PC/37:0 PE 
  x   x x 
745.6 
40:0 PA/ 40:1 
PA/40:8 PA 
  x   x x 
742.6 
34:2 PCp/34:3 
PCe/36:3 PE 
x x x x x 
741.5 34:5 PG   x   x x 
740.5 33:4 PC/36:4 PE   x   x x 
739.4 34:6 PG   x   x   
738.4 
36:4 
PE/34:4/36:5 PE 
x x x x   
737.5 34:6 PG x x   x x 
736.5 
36:5 PE/32:0 
PS/33:0 PSe 
x x   x x 
735.5 34:0 PGe x x x x x 
 132 
m/z  
Bligh and Dyer 
Extraction 
Silica Phase C18 Phase 
MeOH IPA ACN 
2:1 
Chloroform
/MeOH 
1:1 
Tetrahydrofuran 
/MeOH 
734.5 
33:0 PS/32:0 
PS/36:0 PEe 
x x x x x 
733.5 
34:0 PGp/34:1 
PGe 
x x   x x 
732.6 
32:1 PC/36:0 
PEp /36:1 PEe 
x x x x x 
730.4 
32:2PC/35:2 
PE/36:0 
Pep/36:1 PEe 
x     x x 
729.4 33:4 PG x x   x x 
728.5 
32:3 PS/36:1 
PEp 
x x x x x 
725.4 26:1 PI x x   x x 
724.5 
32:6 PS/32:5 
PC/36:5 PE/36:3 
Pep36:4 PEe 
x     x x 
723.6 33:0 PG/38:5 PA   x   x x 
718.5 
32:1 PC/32:0 
PC/35:0 PE/34:0 
PE 
x x x x x 
716.6 32:1 PC/35:1 PE   x   x x 
714.4 34:3 PE/31:3 PC x x x x x 
711.4 32:6 PG/38:3 PA           
708.4 34:6 PE/31:0 PS   x   x x 
707.5 
32:0 PGe/38:4 
Pap/38:5 PAe 
x x   x x 
706.6 31:0 PC/34:0 PE   x   x x 
704.6 34:0PE/34:1 PE   x     x 
703.6 37:0 PA/37:1 PA   x   x x 
702.5 30:2 PC/33:2 PE   x   x x 
701.5 36:1 PA x     x x 
698.4 30:5 PS/34:3 PE       x x 
697.3 24:1 PI/36:4 PA       x x 
694.5 29:0 PS/30:0 PS       x x 
692.6 
30:0 PCe/30:0 
PS /32:0 PE 
x x   x x 
690.5 
30:0 PC/30:1 
PCe /32:1 PE 
x x x x x 
688.5 
32:2 PE/30:1 
PCp 
x     x   
 133 
m/z  
Bligh and Dyer 
Extraction 
Silica Phase C18 Phase 
MeOH IPA ACN 
2:1 
Chloroform
/MeOH 
1:1 
Tetrahydrofuran 
/MeOH 
686.5 32:3 PE x x x x x 
683.4 
36:2 Pap/36:3 
PAe 
x     x x 
680.4 32:6 PE/28:0 PS       x   
679.5 
30:0 PGe/36:4 
PAp 
x     x x 
678.5 
28:0 PS/32:6 
PE28:0/PC, 28:1 
PS/32:0 PEe 
x     x x 
677.5 34:0 PA x     x x 
676.5 
28:0 PC/28:1 PS 
/32:0 PEe 
x     x x 
676.4 29:2 PG/28:2 PS       x x 
675.4 18:3 Pip/34:0 PA x     x x 
674.5 28:2 PC/31:2 PE       x x 
673.4 
35:2 PA/35:1 
PA/34:1 PA 
x x   x   
673.4 34:2 PA x     x   
672.4 
31:3 PE/28::3 
PC 
          
671.5 34:2 PA x     x x 
667.4 
18:0 PIp/34:5 
PA 
      x x 
664.5 28:0 PC/30:0 PE x     x x 
663.6 34:0 PA/33:0 PA   x   x x 
662.6 28:0 PC/30:1 PE x x x x x 
660.5 
28:0 PCp/30:1 
PE/30:2 PE 
x     x x 
655.5 
22:0 LPI/34:2 
Pap/34:3 PAe 
x     x x 
654.4 30:5 PE/30:4 PE x     x x 
653.5 28:0 PG/33:5 PA   x   x x 
651.4 
16:0 LPIP/22:2 
LPI/28:0 PGe 
x x   x   
650.4 26:1 PS/26:0 PC   x   x x 
649.2 16:1 LPIP x x   x x 
647.3 
22:4 LPI/32:0 
PA 
x x x x x 
643.3 20:0 PI/21:0 PI       x x 
639.4 32:4 PA x     x x 
 134 
m/z  
Bligh and Dyer 
Extraction 
Silica Phase C18 Phase 
MeOH IPA ACN 
2:1 
Chloroform
/MeOH 
1:1 
Tetrahydrofuran 
/MeOH 
638.4 26:1 PG/26:0 PS x     x x 
636.5 26:0 PS/29:0 PE       x x 
634.5 
26:0 PCe/28:0 
PE/26:0 PCp/ 
28:1 PE 
x     x x 
633.5 
32:0 PA/32:1 
PA/31:1 PA 
      x x 
627.4 
20:0 LPI/31:3 
PA 
x x x x x 
623.4 26:0 PG x     x x 
622.5 
24:0 PC/28:0 
PEe 
x x   x x 
620.4 24:1 PC/8:0 PEp x     x x 
618.4 
24:1 PC/28:0 
PEp 
x     x x 
611.4 
30:5 PA/20:0 
LPI/30:4 PA 
x x   x x 
608.3 23:0 PC/26:0 PE x     x   
603.5 30:1 PA/30:0 PA x     x x 
597.3 
23:0 PG/18:1 
LPI 
x     x   
594.4 22:0 PC/25:0 PE       x x 
589.4 28:2 PA x     x x 
585.4 
18:0 PI/17:1 
PI/28:3 PA 
x     x x 
583.3 
22:0 PG/18:0 
LPI 
x x x x   
581.3 22:0 PS/22:0 PG x x x x   
580.4 24:0 PE/22:0 PC       x x 
570.4 
22:6 PS/22:5 
LPC 
x     x x 
569.4 
22:0 LPG/16:1 
LPI 
x     x x 
568.3 
20:0 LPS/21:0 
LPS/22:6 
LPS/22:6 LPC 
x     x x 
566.3 
20:0 
LPC/23:0/21:0 
LPS LPE 
x     x   
559.3 
15:0 LPI/16:0 
LPI 
      x   
 135 
m/z  
Bligh and Dyer 
Extraction 
Silica Phase C18 Phase 
MeOH IPA ACN 
2:1 
Chloroform
/MeOH 
1:1 
Tetrahydrofuran 
/MeOH 
555.3 
16:0 LPI/21:0 
LPG 
      x   
552.6 
20:1 LPS/22:0 
LPE/20:0 LPC 
      x   
550.4 
20:2 LPS/20:1 
LPS 
x x x x   
544.5 20:4 LPC x x   x   
543.3 14:1 LPI       x   
537.3 
20:2 LPG/24:0 
LPA 
      x x 
536.3 
22:1 LPE/20:0 
LPC 
      x   
535.4 
24:1 LPA/20:3 
LPG 
      x x 
532.3 
13:0 LPI/22:2 
LPE 
x         
524.3 
18:1 LPS/20:0 
LPE 
      x   
523.3 23:0 LPA           
522.4 
18:1 LPC/18:0 
LPC 
x x x x x 
518.3 
18:3 LPC/18:2 
LPC 
x x   x   
510.3 
17:1 LPS/18:0 
LPS 
          
508.3 
18:0 LPC/17:1 
LPC 
          
506.3 
17:2 LPC/20:2 
LPE/20:1 LPE 
x         
500.3 20:5 LPE x x   x x 
497.3 
18:0 LPG/17:1 
LPG 
          
496.6 
16:1 LPS/20:0 
LPE/16:0 LPC 
x     x x 
495.4 22:0 LPA           
494.2 
20:0 LPE/16:1 
LPS/16:1 LPC 
x x   x   
481.4 
21:0 LPA/20:0 
LPA 
          
480.4 16:0 LPC           
478.3 18:2 LPE           
 136 
m/z  
Bligh and Dyer 
Extraction 
Silica Phase C18 Phase 
MeOH IPA ACN 
2:1 
Chloroform
/MeOH 
1:1 
Tetrahydrofuran 
/MeOH 
468.5 
18:0 LPE/17:0 
LPE 
x     x   
467.3 20:0 LPA           
466.3 
14:1 LPC/17:1 
LPE/18:0 LPE 
  x   x   
465.4 20:1 LPA           
464.2 17:2 LPE           
456.3 13:0 LPS           
455.2 
13:0 LPC/16:0 
LPE/14:0 LPG 
x         
453.4 
20:0 LPA/19:0 
LPA 
          
442.3 12:0 LPS           
440.5 16:0 LPE x x       
425.3 
17:0 LPA/18:0 
LPA 
  x       
412.3 
10:0 LPC/13:0 
LPE 
          
353.2 12:0 LPA x         
327.2 10:0 LPA           
Table A-1 Library of Identified glycerophospholipd species eluted by different eluents on silica or 
C18 stationary phases compared to total lipid species by Bligh and Dyer method for evaluation of 
on-chip extraction efficiency.  The matched glycerophospholipid species are marked by “x” within 
a mass error window of 10 ppm.  Phospholipids are presented with a class abbreviation preceded 
by xx:y, where xx is the total fatty acid carbon number and y is the number of double bonds.  The 
following abbreviations are used: PA, phosphatidic acid; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PG, phosphatidylglycerol;  PI, phosphatidylinositol; PS, 
phosphatidylserine; LPA, lysophosphatidic acid; LPC, lysophosphatidylcholine; LPE, 
lysophosphatidylethanolamine; LPG, lysophosphatidylglycerol; LPI, lysophosphatidylinositol; LPS, 
lysophosphatidylserine; PIP, phosphatidylinositol phosphate.  PC, PE, PI and PIP with a lower 
case e and/or p refer to plasmanyl and plasmenyl (alkyl ether and plasmalogens) subspecies, 
respectively. 
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Appendix 2 
 
 
Library of Identified Phospholipid Species in 
Sulfurospirillum barnesii Cells Extracted from the 
Microchip 
 
A.2 Abstract 
 
A library for identified glycerophospholipids extracted from Sulfurospirillum 
barnesii strain SES-3 cells based on the matches of METLIN Personal Metabolite 
database and LIPID MAPS database was established.  The glycerophospholipids were 
extracted by using methanol as the eluent on microchip packed with silica stationary 
phase. 
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Measured 
mass 
Theoretical 
mass 
Error 
(ppm) 
Ionization mode 
Negative Positive 
353.177 353.173 9.6 12:0 LPA  
431.219 431.220 -2.8 18:3 LPA  
440.492 440.494 -4.5  16:0 LPE 
455.245 455.242 8.3 14:0 LPG  
468.507 468.505 5.3  18:0 LPE 
494.250 494.252 -5.3 16:1 LPS  
494.227 494.224 6.5  16:1 LPC 
496.643 496.640 5.4  16:0 LPC 
500.381 500.377 8.4  20:5 LPE 
506.322 506.325 -7.5 20:1 LPE  
506.320 506.324 -8.9  20:2 LPE 
518.360 518.359 1.9 18:2 LPC  
518.329 518.324 8.8  18:3 LPC 
522.350 522.353 -5.6 18:0 LPC  
522.360 522.355 9.6  18:1 LPC 
532.345 532.341 8.5 22:2 LPE  
544.542 544.540 3.7  20:4 LPC 
550.313 550.315 -4.4 20:1 LPS  
550.382 550.386 -7.3  20:1 LPC 
552.605 552.602 5.4  20:0 LPC 
566.350 566.346 7.2 21:0 LPS  
568.271 568.268 4.9 22:6 LPS  
568.337 568.334 5.3  22:6 LPC 
569.350 569.353 -5.1 16:1 LPI  
570.360 570.356 7.0  22:5 LPC 
581.351 581.346 8.9 22:0 PG  
583.322 583.325 -6.2 18:0 LPI  
585.361 585.356 8.4 28:3 PA  
589.384 589.388 -5.4 28:1 PA  
597.301 597.305 8.7 18:1 LPI  
603.454 603.450 7.5 30:0 PA  
608.331 608.329 3.3  26:0 PE 
611.363 611.357 a/o 
611.369 
9.9 a/o -
9.9 
20:0 LPI a/o 30:4 PA  
618.419 618.414 a/o 
618.420 
7.8 a/o -
2.6 
24:1 PC a/o 28:0 PEp  
620.633 620.629 a/o 
620.635 
6.4 a/o -
3.2 
 24:1 PC a/o 28:0 PEp 
622.492 622.494 a/o 
622.489 
-3.2 a/o 
4.8 
 24:0 PC a/o 28:0 PEe 
627.397 627.392 a/o 
627.402 
8.1 a/o -
7.7 
20:0 LPI a/o 31:3 PA  
634.475 634.480 a/o 
634.470 
-8.0 a/o 
7.6 
26:0 PCe a/o 28:0 PE  
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Measured 
mass 
Theoretical 
mass 
Error 
(ppm) 
Ionization mode 
Negative Positive 
634.486 634.481 a/o 
634.490 
7.9 a/o -
6.3 
 26:0 PCp a/o 28:1 PE 
638.446 638.439 10.0  26:0 PS 
639.407 639.403 5.9 32:4 PA  
647.315 647.320 a/o 
647.310 
-8.8 a/o 
7.4 
22:4 LPI a/o 32:0 PA   
649.246 649.240 9.2 16:1 LPIP  
651.357 651.355, 
651.352 a/o 
651.361 
3.0, 7.7 
a/o -6.1 
16:0 LPIP, 22:2 LPI 
a/o 28:0 PGe 
 
654.416 654.414 3.1 30:4 PE  
654.418 654.413 7.6  30:5 PE 
655.479 655.483, 
655.476 a/o 
655.476 
-6.1, 4.6 
a/o 4.6 
22:0 LPI, 34:2 PAp a/o 
34:3 PAe 
 
660.494 660.497 a/o 
660.489 
-4.5 a/o 
7.6 
28:0 PCp a/o 30:1 PE  
660.457 660.460 -4.5  30:2 PE 
662.616 662.612 a/o 
662.622 
6.0 a/o -
9.1 
 28:0 PC a/o 30:1 PE 
664.527 664.528 a/o 
664.531 
-1.5 a/o -
6.0 
 28:0 PC a/o 30:0 PE 
671.538 671.536 3.0 34:2 PA  
673.376 673.381 -7.4 34:1 PA  
675.399 675.397 2.9 34:0 PA  
676.501 676.497, 
676.504 a/o 
676.504 
5.9, -4.4 
a/o -4.4 
28:0 PC, 28:1 PS a/o 
32:0 PEe 
 
676.497 676.491, 
676.502 a/o 
676.502 
8.9, -7.4 
a/o -7.4 
 28:1 PC, 32:0 PEp 
a/o 32:1 PEe 
678.429 678.435 a/o 
678.424 
-8.7 a/o 
7.4 
28:0 PS a/o 32:6 PE  
678.511 678.507, 
678.514 a/o 
678.513 
5.9, -4.4 
a/o -2.9 
 28:0 PC, 28:1 PS a/o 
32:0 PEe 
679.487 679.492 a/o 
679.481 
-7.4 a/o 
8.8 
30:0 PGe a/o 36:4 PAp  
683.606 683.602 a/o 
683.602 
5.9 a/o 
5.9 
36:2 PAp a/o 36:3 PAe  
686.478 686.476 2.9  32:3 PE 
688.501 688.495 a/o 
688.508 
8.7 a/o -
10.0 
 32:2 PE a/o 30:1 PCp 
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Measured 
mass 
Theoretical 
mass 
Error 
(ppm) 
Ionization mode 
Negative Positive 
690.549 690.543, 
690.543 a/o 
690.552 
8.7, 8.7 
a/o -4.3 
 30:0 PC, 30:1 PCe 
a/o 32:1 PE 
692.564 692.559, 
692.566 a/o 
692.563 
7.2, -2.9 
a/o 1.4 
 30:0 PCe, 30:0 PS 
a/o 32:0 PE 
701.509 701.513 -5.7 36:1 PA  
707.519 707.523, 
707.512 a/o 
707.512 
-6.0, 9.9 
a/o 9.9 
32:0 PGe, 38:4 PAp 
a/o 38:5 PAe 
 
714.398 714.394 5.6  34:3 PE 
718.602 718.599 4.2 34:0 PE  
718.500 718.495, 
718.495 a/o 
718.498 
9.7, 9.7 
a/o 5.6 
 32:0 PCp, 32:1 PCe 
a/o 34:1 PE 
724.530 724.529 a/o 
724.529 
1.3 a/o 
1.3 
36:3 Pep a/o 36:4 PEe  
724.520 724.525, 
724.518 a/o 
724.518 
-4.1, 5.5 
a/o 5.5 
 32:5 PC, 36:4 PEp 
a/o 36:5 PEe 
728.457 728.451 a/o 
728.460 
8.2 a/o 
4.4 
32:3 PS a/o 36:1 PEp  
728.556 728.553 
728.559 a/o 
728.559 
4.3, -4.0 
a/o -4.0 
 32:3 PC, 36:2 PEp 
a/o 36:3 PEe 
730.474 730.476 a/o 
730.476 
-2.7 a/o -
2.7 
36:0 PEp a/o 36:1 PEe  
730.440 730.438, 
730.445 a/o 
730.445 
2.7, -6.8 
a/o -6.8 
 32:2 PC, 36:1 PEp 
a/o 36:2 PEe 
732.583 732.576, 
732.590 a/o 
732.590 
9.6, -8.8 
a/o -8.8 
 32:1 PC, 36:0 PEp 
a/o 36:1 PEe 
733.442 733.439 a/o 
733.439 
4.1 a/o 
4.1 
34:0 PGp a/o 34:1 PGe  
734.504 734.498 4.1 32:0 PS  
734.572 734.570 a/o 
734.569 
2.7 a/o 
4.1 
 32:0 PC a/o 36:0 PEe   
735.461 735.455 8.2 34:0 PGe  
736.499 736.492 9.5 36:5 PE  
736.507 736.512 a/o 
736.509 
-6.7 a/o -
2.7 
 32:0 PS a/o 33:0 PSe 
737.543 737.540 4.1 34:6 PG   
738.402 738.408 -8.1 36:4 PE   
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Measured 
mass 
Theoretical 
mass 
Error 
(ppm) 
Ionization mode 
Negative Positive 
738.435 738.430 a/o 
738.437 
6.8 a/o -
3.3 
 34:4 a/o 36:5 PE 
742.583 742.575, 
742.575 a/o 
742.588 
10.0, 10.0 
a/o -6.7 
 34:2 PCp, 34:3 PCe 
a/o 36:3 PE 
749.429 749.425 a/o 
749.434 
5.3 a/o -
6.7 
28:2 PI a/o 34:0 PG  
752.566 752.560 a/o 
752.560 
7.9 a/o 
7.9 
38:3 PEp a/o 38:4 PEe  
752.565 752.563, 
752.559 a/o 
752.559 
2.7, 8.0 
a/o 8.0 
 34:5 PC, 38:4 PEp 
a/o 38:5 PEe 
753.509 753.516, 
753.508 a/o 
753.508 
-9.3, 1.3 
a/o 1.3 
28:0 PI, 36:4 PGp a/o 
36:5 PGe 
 
754.571 754.576 a/o 
754.576 
-6.6 a/o -
6.6 
38:2 PEp a/o 38:3 PEe  
754.544 754.538, 
754.545 a/o 
754.545 
7.9, -1.3 
a/o -1.3 
 34:4 PC, 38:3 PEp 
a/o 38:4 PEe 
757.542 757.539 a/o 
757.539 
4.0 a/o 
4.0 
36:2 PGp a/o 36:3 PGe  
758.711 758.707 a/o 
758.707 
5.3 a/o 
5.3 
38:0 PEp a/o 38:1 PEe  
758.561 758.568 -9.2  34:2 PC 
760.728 760.723 6.6 38:0 PEe  
760.627 760.631, 
760.622 a/o 
760.622 
-5.3, 6.6 
a/o 6.6 
 34:1 PC, 38:0 PEp 
a/o 38:1 PEe 
765.498 765.492 a/o 
765.492 
7.8 a/o 
7.8 
30:0 PIp a/o 30:1 PIe  
766.546 766.539 9.1 38:4 PE  
766.463 766.465 a/o 
766.458 
-2.6 a/o 
6.5 
 36:4 PCp a/o 38:5 PE 
767.512 767.508 5.2 30:0 PIe  
768.550 768.555 -6.5 38:3 PE  
768.449 768.454, 
768.446 a/o 
768.446 
-6.5, 3.9 
a/o 3.9 
 38:4 PE, 36:3 PCp 
a/o 36:4 PCe 
771.414 771.409 a/o 
771.418 
6.5 a/o -
5.2 
30:5 PI a/o 36:3 PG  
776.565 776.558, 
776,560 a/o 
776.560 
9.0, 6.4 
a/o 6.4 
36:0 PSe, 40:5 PEp a/o 
40:6 PEe 
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Measured 
mass 
Theoretical 
mass 
Error 
(ppm) 
Ionization mode 
Negative Positive 
776.562 776.563, 
776.556 a/o 
776.559 
-1.3, 7.7 
a/o 3.9 
 36:0 PCe, 38:0 PE 
a/o 40:6 PEp 
782.579 782.573 a/o 
782.586 
7.7 a/o -
8.9 
 36:4 PC a/o 40:4 PEe 
784.616 784.613, 
784.623 a/o 
784.623 
3.8, -8.9 
a/o -8.9 
36:3 PS, 40:1 PEp a/o 
40:2 PEe 
 
784.623 784.628, 
784.617, 
784.622 a/o 
784.622 
-6.4, 7.6, 
1.3 a/o 
1.3 
 36:3 PC, 36:4 PS, 
40:2 PEp a/o 40:3 
PEe 
786.546 786.541, 
786.548, 
786.540 a/o 
786.540 
6.4, -2.5, -
5.1 a/o -
5.1 
 36:2 PC, 36:3 PS, 
40:1 PEp a/o 40:2 
PEe 
790.667 790.662, 
790.659 a/o   
790.668 
6.3, 10.0 
a/o -1.3 
 36:0 PC, 36:1 PS a/o 
40:0 PEe 
795.543 795.539 a/o 
795.548 
5.0 a/o -
6.3 
32:0 PIe a/o 38:5 PG   
796.557 796.552, 
796.552, 
796.549 a/o 
796.555 
6.3, 6.3, 
10.0 a/o 
2.5 
 38:3 PCp, 38:4 PCe, 
38:4 PSp a/o 40:4 PE 
798.539 798.537, 
798.537, 
798.544 a/o 
798.541 
2.5, 2.5, -
6.3 a/o -
2.5 
 38:2 PCp, 38:3 PCe, 
38:3 PSp a/o 40:3 PE 
800.659 800.653, 
800.653, 
800.652 a/o 
800.666 
7.5, 7.5, 
8.7 a/o -
8.7  
 38:1 PCp, 38:2 PCe, 
38:2 PSp a/o 40:2 PE 
802.670 802.668, 
802.668, 
802.676 a/o 
802.672 
2.5, 2.5, -
7.5 a/o -
2.5  
 38:0 PCp, 38:1 PCp, 
38:1 PSp a/o 40:1 PE 
805.637 805.633 5.0 38:0 PG  
806.566 806.559, 
806.570, 
806.569 a/o 
806.569 
8.7, -5.0, -
3.7 a/o -
3.7 
 38:0 PSe, 38:6 PC, 
42:5 PEp a/o 42:6 
PEe 
810.537 810.529 a/o 
810.538 
9.9 a/o -
1.2 
38:4 PS a/o 42:2 PEp  
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Measured 
mass 
Theoretical 
mass 
Error 
(ppm) 
Ionization mode 
Negative Positive 
810.533 810.531, 
810.528 a/o 
810.537 
2.5, 6.2 
a/o -4.9 
 38:4 PC, 38:5 PS a/o 
42:4 PEe 
812.478 812.473 a/o 
812.482 
6.2 a/o -
4.9 
38:3 PS a/o 42:2 PEe  
812.657 812.661, 
812.649 a/o 
812.653 
-4.9, 9.8 
a/o 4.9 
 38:3 PC, 38:4 PS a/o 
42:2 PEp 
816.579 816.576 a/o 
816.585 
3.7 a/o -
7.3 
38:1 PS a/o 42:0 PEe  
816.581 816.584, 
816.575 a/o 
816.584 
-3.7, 7.3 
a/o -3.7 
 38:1 PC, 38:2 PS a/o 
42:0 PE 
818.605 818.603, 
818.597 a/o 
818.606 
2.4, 9.8 
a/o -1.2 
 38:0 PC, 38:1 PS a/o 
40:6 PCp 
820.598 820.606, 
820.602 a/o 
820.595 
-9.7, -4.9 
a/o 3.7 
 38:0 PS, 40:5 PCp 
a/o 40:6 PS 
822.539 822.537, 
822.544 a/o 
822.541 
2.4, -6.1 
a/o -2.4 
 40:4 PCp, 40:5 Pce 
a/o 40:5 PSp 
830.631 830.628 a/o 
830.628 a/o 
830.634 
3.6, 3.6 
a/o -3.6 
40:0 PSp, 40:1 Pse a/o 
42:0 PE 
 
830.696 830.700, 
830.700 a/o 
830.693 
-4.8, -4.8 
a/o 3.6 
 40:0 PCp, 40:1 Pce 
a/o 40:1 PSp 
831.507 831.503 a/o 
831.512 
4.8 a/o -
6.0 
34:3 PI a/o 40:1 PG  
835.585 835.584 1.2 34:1 PI  
836.552 836.545 8.4 40:5 PS  
836.660 836.657 a/o 
836.654 
3.6 a/o 
7.2 
 40:5 PC a/o 40:6 PS 
846.701 846.696, 
846.703 a/o 
846.705 
5.9, -2.4 
a/o -4.7 
42:6 PSp, 40:0 PS a/o 
44:6 PE 
 
846.629 846.625, 
846.622 a/o 
846.637 
4.7, 8.3 
a/o -9.4 
 40:0 PC, 40:1 PS a/o 
42:6 PCp 
847.577 847.580, 
847.571 a/o 
847.571 
-3.5, 7.1 
a/o 7.1 
42:0 Pge, 36:1 PIp a/o 
36:2 PIe 
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Measured 
mass 
Theoretical 
mass 
Error 
(ppm) 
Ionization mode 
Negative Positive 
848.601 848.595 a/o 
848.608 
7.1 a/o -
8.2 
42:5 PS a/o 44:5 PE  
848.640 848.633, 
848.638 a/o 
848.646 
8.3 2.4 
a/o -7.1 
 42:6 Pce, 40:0 PS a/o 
44:6 PE 
850.595 850.603 a/o 
850.597 
-9.4 a/o -
2.4 
44:4 PE a/o 42:5 PSe  
850.677 850.672, 
850.668 a/o 
850.668 
5.9, 10  
a/o 10.0 
 44:5 PE, 42:4 PCp 
a/o 42:5 PCe 
856.650 856.643 a/o 
856.659 
8.2 a/o -
10.0 
 42:2 PSp a/o 44:2 PE 
857.509 857.505 a/o 
857.512 
5.8 a/o -
4.7 
36:4 PI a/o 42:2 PG  
858.703 858.701, 
858.701 a/o 
858.697 
2.3, 2.3 
a/o 7.0 
 42:0 PCp, 42:1 PCe 
a/o 44:1 PE 
861.653 861.650 a/o 
861.659 
3.5 a/o -
7.0 
36:2 PI a/o 42:0 PG  
864.555 864.557 -3.5 42:5 PS  
864.541 864.545 a/o 
864.548 
-4.6 a/o -
8.1 
 42:5 PC a/o 42:6 PS 
866.700 866.692 9.2 42:4 PS  
866.669 866.663 a/o 
866.671 
6.9 a/o -
2.3 
 42:4 PC a/o 42:5 PS 
868.611 868.607 4.6 42:3 PS  
868.603 868.599 a/o 
868.606 
4.6 a/o -
3.5 
 42:3 PC a/o 42:4 PS 
877.613 877.618 a/o 
877.618 
-5.7 a/o -
5.7 
38:0 PIp a/o 38:1 PIe  
880.682 880.679 3.4  43:4 PC 
881.482 881.477 6.8 38:6 PI  
890.638 890.632 7.9 44:6 PS  
890.670 890.663 4.2  44:6 PC 
892.602 892.607 -5.6 44:5 PS  
     
892.610 892.606 a/o 
892.619 
4.5 a/o -
10.0 
 44:6 PS a/o 44:5 PC 
894.702 894.696 6.7 44:3 PC  
894.697 894.695 a/o 
894.702 
2.2 a/o -
5.6 
 44:4 PC a/o 44:5 PS 
898.503 898.509 -7.8 44:2 PS  
898.629 898.626 a/o 
898.633 
3.3 a/o -
4.5 
 44:2 PC a/o 44:3 PS 
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Measured 
mass 
Theoretical 
mass 
Error 
(ppm) 
Ionization mode 
Negative Positive 
899.497 899.502 a/o 
899.502 
-5.6 a/o -
5.6 
40:3 PIp a/o 40:4 PIe  
901.514 901.518 a/o 
901.518 
-4.4 a/o -
4.4 
40:2 PIp a/o 40:3 PIe  
921.483 921.486 -3.3 42:6 PIp  
923.607 923.602 a/o 
923.602 
5.4 a/o 
5.4 
42:5 PIp a/o 42:6 PIe  
929.657 929.649 8.6 42:2 PIp  
945.650 945.644 6.3 42:2 PI  
953.562 953.553 a/o 
953.553 
9.4 a/o 
9.4 
38:2 PIPp a/o 38:3 
PIPe 
 
955.571 955.568 a/o 
955.568 
3.1 a/o 
3.1 
38:1 PIPp a/o 38:2 
PIPe 
 
957.589 957.584 a/o 
957.584 
5.2 a/o 
5.2 
38:0 PIPp a/o 38:1 
PIPe 
 
963.508 963.501 7.3 38:5 PIP  
969.638 969.633 a/o 
969.644 
5.2 a/o -
6.2 
38:2 PIP a/o 44:4 PI  
973.584 973.579 a/o 
973.575 
5.1 a/o 
9.2 
38:0 PIP a/o 44:2 PI  
979.570 979.568 a/o 
979.568 
2.0 a/o 
2.0 
40:3 PIPp a/o 40:4 
PIPe 
 
Table A-2 Library of identified phospholipid species extracted from cells by microchip. 
Phospholipids are presented with a class abbreviation preceded by xx:y, where xx is the total 
fatty acid carbon number and y is the number of double bonds.  The following abbreviations are 
used: PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, 
phosphatidylglycerol;  PI, phosphatidylinositol; PS, phosphatidylserine; LPA, lysophosphatidic 
acid; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; LPG, 
lysophosphatidylglycerol; LPI, lysophosphatidylinositol; LPS, lysophosphatidylserine; PIP, 
phosphatidylinositol phosphate.  PC, PE, PI and PIP with a lower case e and/or p refer to 
plasmanyl and plasmenyl (alkyl ether and plasmalogens) subspecies, respectively. 
 
 
 
 
